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Summary 
Long-term potentiation (LTP) and depression (LTD) at glutamatergic synapses are intensely 
investigated processes for understanding the synaptic basis for learning and memory, but the 
underling molecular mechanisms remain poorly understood.  We have made three novel mouse 
lines where the C-terminal domains (CTDs) of endogenous AMPA receptors (AMPARs), the 
principal mediators of fast excitatory synaptic transmission, are specifically exchanged.  These 
mice display profound deficits in synaptic plasticity without any effects on basal synaptic 
transmission.  Our study reveals that the CTDs of GluA1 and GluA2, the key subunits of 
AMPARs, are necessary and sufficient to drive NMDA receptor-dependent LTP and LTD, 
respectively.  In addition, these domains exert differential effects on spatial and contextual 
learning and memory.  These results establish dominant roles of AMPARs in governing 
bidirectional synaptic and behavioral plasticity in the CNS. 
 
Long-term potentiation (LTP) and depression (LTD) are the most extensively studied forms of synaptic 
plasticity, widely regarded as the cellular basis for learning and memory1-3.  Deficits in LTP and LTD 
are associated with animal models of many neurological and mental disorders4.  Thus, the mechanisms 
governing these forms of plasticity have been the subject of intensive investigations during the last few 
decades.  Numerous studies have focused on the AMPA subtype of glutamate receptors (AMPARs) 
because these receptors are the principal mediator of fast, excitatory synaptic transmissions in the 
mammalian CNS.  This has led to a major hypothesis that GluA1 and GluA2, the key subunits of 
AMPARs, are crucial for LTP and LTD, respectively5-8.  However, this idea has been challenged in 
recent genetic studies showing that both LTP and LTD can be established in the absence of AMPAR 
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subunits8-11.  Therefore, despite intense studies, the fundamental mechanisms underlying synaptic 
plasticity remain elusive4,8. 
 
A major reason for the controversy is that many previous studies have employed exogenously expressed, 
non-physiological homomeric receptors (e.g. refs 12,13), whose behavior may not be the same as the 
more commonly expressed native, hetero-tetrameric AMPARs.  Small peptides have been used to 
disrupt protein interactions at endogenous AMPARs13-18, but they have the limitation of potential off-
target effects.  Genetic studies (e.g. global or conditional KO mice) have also been compromised by the 
formation of non-physiological receptors, leading to dramatic alterations in baseline AMPAR properties 
or synaptic function9,10,19-21, which makes the interpretation inconclusive.  Specifically, the ablation of 
the GluA1 subunit causes impairments in receptor assembly and trafficking9,22 and consequently a 
drastic reduction in basal synaptic transmission9,10,20,23, which confounds the analysis of synaptic 
plasticity.  Similarly, deletion of the GluA2 subunit results in the formation of aberrant receptors24, 
altered biophysical properties and severely reduced synaptic strength9,11,19,21.  Significantly, GluA2-
lacking receptors are Ca2+ permeable and their activation can induce various forms of plasticity19,25 that 
can alter the physiology of neurons and, in some cases, even trigger cell death26.  In studies using mice 
where all major AMPAR subunits are deleted using a cell-specific Cre/loxP method9-11, synaptic 
mechanisms in these mice will unlikely reflect those operating under normal physiological conditions, 
where the full native AMPAR complement is present.  Knock in (KI) mouse models involving mutations 
of individual amino acids of AMPARs have been created but are limited by relatively mild phenotypes 
and therefore have not been able to provide definitive answers27,28. 
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Therefore, we reasoned that removing the entire subunit of GluA1 or GluA2 is not an ideal approach to 
address the role of AMPARs in plasticity.  We therefore have developed three new mouse models where 
only specific domains of endogenous AMPARs are switched, which allowed synaptic plasticity to be 
systematically and definitively analyzed without confounding effects on basal synaptic transmission.  
Using these mice we revealed that the CTDs of native GluA1 and GluA2 are necessary and sufficient for 
LTP and LTD expression, respectively and regulate distinct forms of learning and memory. 
 
RESULTS 
Basal synaptic and AMPAR properties in GluA1C2KI and GluA2C1KI mice 
We used the homologous recombination strategy in ES cells to generate three novel CTD replacement 
mutant mice: GluA1C2KI where the CTD of GluA1 was replaced by that of GluA2, GluA2C1KI where the 
CTD of GluA2 was replaced by that of GluA1, and, by crossing these two strains, GluA1C2KI/GluA2C1KI 
where the CTDs of GluA1 and GluA2 were swapped (Fig. 1a,b and Supplementary Fig. S1, S2).  The 
CTD replacements in these mice were confirmed by PCR and Southern blot analysis of ES cell and tail 
DNA followed by western blot analysis of the brain protein lysates (Supplementary Fig. S1, Fig. S2a-
e, Fig. S9 and Fig. S10).  In contrast to GluA2 KO mice, which exhibited increased mortality, growth 
retardation and severe motor deficits19,29, neither GluA1C2KI nor GluA2C1KI mice showed any alterations 
in viability, developmental growth, life span, fertility or home-cage behaviors.  Histochemical analyses 
showed that both strains of mice have intact brain structure, normal synapse (Supplementary Fig. 
S2f,g) and AMPAR distribution profiles (Supplementary Fig. S2h,i) in the hippocampus.  
 
To examine basal synaptic and AMPAR properties in these mice, we first compared input/output curves 
of field excitatory postsynaptic potentials (fEPSPs), but found no significant differences between WT, 
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GluA1C2KI  (Fig. 1c) and GluA2C1KI (Fig. 1d) mice.  Next, we used whole-cell patch-clamp recordings of 
CA1 neurons to examine excitatory postsynaptic currents (EPSCs) mediated by NMDARs (EPSCNMDAR) 
and AMPARs (EPSCAMPAR), but found no differences in EPSCNMDAR/EPSCAMPAR ratios between WT, 
GluA1C2KI  and GluA2C1KI mice (Fig. 1e).  This was in marked contrast to GluA2 KO mice that showed 
a 3-fold increase in the EPSCNMDAR/EPSCAMPAR ratio, indicative of the severe reduction in AMPAR-
mediated EPSCs in these mice15,25,26 (Fig. 1e).  Consistent with the lack of effect on basal synaptic 
transmission, we found no differences in the frequency or amplitude of miniature EPSCs (mEPSCs) 
between WT, GluA1C2KI and GluA2C1KI mice (Fig. 1f).  Since the deletion of GluA1 causes a dramatic 
reduction in surface extra-synaptic AMPARs9,10,23, we assessed glutamate evoked currents in outside-out 
patch experiments, but found no significant differences between WT, GluA1C2KI and GluA2C1KI mice 
(Fig. 1g).  To assess the ion channel properties of AMPARs, we analyzed the current/voltage (I/V) 
relationship of AMPAR-mediated currents, but again found no differences between WT, GluA1C2KI and 
GluA2C1KI mice (Fig. 1h).  The linear I/V curves in these mice differ clearly from the strongly rectified 
I/V relationship of GluA2 KO mice (Fig. 1h,i), indicating that channel properties (including polyamine 
sensitivity, receptor composition and Ca2+ permeability) of AMPARs are not altered in GluA1C2KI  or 
GluA2C1KI mice.  Furthermore, NMDAR channel properties as indicated by I/V curves of evoked 
EPSCNMDAR (Fig. 1j) were not altered in GluA1
C2KI or GluA2C1KI mice.  Finally, presynaptic function as 
assessed by paired-pulse facilitation (PPF) was unaffected in these mice (Fig. 1k,l).  Taken together, 
these results indicate that the CTD replacements in GluA1C2KI and GluA2C1KI mice did not significantly 
alter basal synaptic function, receptor assembly, subunit composition or channel properties of AMPARs.  
Therefore, these new mice constitute greatly improved models to specifically address the role of the 
CTDs of endogenous AMPARs in synaptic plasticity. 
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Impaired LTP, but intact LTD, in GluA1C2KI mice 
To determine the role of the CTD of GluA1 in synaptic plasticity, we compared LTP and LTD at CA1 
synapses between WT and GluA1C2KI mice.  As show in Fig. 2a, delivery of high frequency stimulation 
(HFS, 100 pulses at 100 Hz) induced a persistent increase in fEPSP in WT, but this LTP was completely 
abolished in GluA1C2KI mice.  To test the possibility that the lack of LTP in GluA1C2KI mice might be 
due to an impaired threshold for LTP induction, we applied multiple trains of HFS (4 trains with 10 s 
inter-train interval) but, as shown in Fig. 2b, while this protocol produced stable LTP in WT, it failed to 
induce any LTP in GluA1C2KI mice.  We also employed a spaced induction protocol where each of the 
four 100 Hz trains was separated by a 5 min inter-train interval, and found that LTP was significantly 
reduced in GluA1C2KI mice (Fig. 2c).  To ascertain whether the LTP induced by HFS was dependent on 
the activation of NMDARs, we induced LTP in the presence of D-2-amino-5-phosphonopentanoic acid 
(AP5) (100 M) and found that LTP was completed blocked (Fig. 2d).  In contrast to the impaired LTP, 
LTD induced by low frequency stimulation (LFS, 900 pulses at 1 Hz for field recordings and 900 pulses 
at 5 Hz at -40 mV for whole-cell recordings) was indistinguishable between WT and GluA1C2KI mice 
(Fig. 2e).  To investigate whether the LTD induced by the LFS protocol was dependent on the activation 
of NMDARs, we perfused 100 M AP5 10 min before and during the induction protocol, and this 
completely blocked LTD in both WT and GluA1C2KI mice (Fig. 2f).  Consistent with this NMDAR-
dependence, application of MPEP (10 M), a specific antagonist for mGluR5, had no effect on LTD in 
WT or GluA1C2KI mice (Fig. 2g).  These results indicate that the CTD of GluA1 is essential for 
NMDAR-dependent LTP, but not for NMDAR-LTD. 
 
Absence of LTD, but enhanced LTP, in GluA2C1KI mice 
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To determine the role of the CTD of GluA2 in synaptic plasticity, we compared LTP and LTD at the 
CA1 synapse between WT and GluA2C1KI mice.  As shown in Fig. 3a, delivery of LFS (900 pulses at 1 
Hz) induced stable LTD of fEPSPs in WT, but not in GluA2C1KI mice.  Similarly, delivery of LFS (900 
pulses at 5 Hz at -40 mV) in whole cell recordings generated LTD in WT, but not in GluA2C1KI mice 
(Fig. 3b).  To investigate whether the LTD induced by the LFS protocol was dependent on the activation 
of NMDARs, we again tested the effect of AP5 (100 M) and MPEP (10 M).  As shown in Fig. 3c,d, 
AP5, but not MPEP, blocked LTD in WT mice.  As expected, neither drugs had any effect in GluA2C1KI 
mice (i.e. where LTD was absent).  In contrast to the impaired LTD, LTP was readily induced in 
GluA2C1KI mice.  In fact, the magnitude of LTP induced by HFS (100 pulses at 100 Hz) was higher in 
GluA2C1KI mice compared to the WT control (Fig. 3e).  In GluA2 KO mice, there was enhanced LTP 
due to the presence of an additional component of LTP that is dependent on Ca2+-permeable AMPARs 
rather than NMDARs19.  In contrast, in the GluA2C1KI mice, LTP was completely blocked by AP5 (Fig. 
3f).  In conclusion, these results demonstrate that the CTD of GluA2 is essential for NMDAR-dependent 
LTD, but not for NMDAR-dependent LTP. 
 
Intact mGluR-LTD in GluA2C1KI and GluA1C2KI mice 
At the CA1 synapse, mGluR-LTD coexists with NMDAR-LTD.  Although distinct in the induction 
mechanisms, both forms of LTD appear to involve the removal of AMPARs from the synapse2,30,31.  
However, whether or not the mechanisms used to remove these receptors are the same is unknown.  
Therefore, we examined whether GluA2C1KI mice are also impaired in mGluR-LTD.  As shown in Fig. 
3g, delivery of paired-pulse low frequency stimulation (PP-LFS, 900 pairs of pulses at 1 Hz with 50 ms 
pairing interval), a widely used protocol to induce mGluR-LTD32, resulted in an indistinguishable 
amount of LTD between WT and GluA2C1KI mice.  Similarly, PP-LFS elicited an equal amount of LTD 
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in WT and GluA1C2KI mice (Supplementary Fig. S3a).  To ascertain whether the LTD induced by the 
PP-LFS protocol was indeed mGluR-dependent, we applied either AP5 (100 M) or MPEP (10 M).  
As shown in Supplementary Fig. S3b,c, PP-LFS induced LTD in all genotypes was completely 
blocked by MPEP, but not by AP5.  Finally, we also induced mGluR-LTD by bath application of the 
mGluR agonist DHPG (100 M).  As shown in Fig. 3h, DHPG induced equal amounts of LTD in WT 
and GluA2C1KI mice and this DHPG-induced LTD was blocked by MPEP, but not by APV 
(Supplementary Fig. S4).  These results indicate that although the CTD of GluA2 is essential for 
NMDAR-LTD, it is not required for mGluR-LTD. 
 
Restoration of both LTP and LTD in GluA1C2KI/GluA2C1KI double mutant mice 
 
The results so far provide clear evidence that the CTDs of GluA1 and GluA2 are necessary for 
NMDAR-LTP and NMDAR-LTD, respectively, but are these domains within a receptor sufficient?  To 
address this question, we examined LTP and LTD in GluA1C2KI/GluA2C1KI double CTD replacement 
mice.  In these mice, both CTDs of GluA1 and GluA2 are present in the receptor complex, but they are 
linked to different receptor subunits.  If the CTD of GluA1 and GluA2 is the sole determinant within the 
receptor for LTP and LTD, respectively, then one would expect that both LTP and LTD would be 
restored in the double mutant mice.  As shown in Fig. 4a, delivery of HFS (100 pulses at 100 Hz) 
generated an indistinguishable amount of LTP in WT and GluA1C2KI/GluA2C1KI mice.  Similarly, 
delivery of 4 trains of HFS (10 s inter-train interval) also resulted in the same amount of LTP in WT and 
GluA1C2KI/GluA2C1KI mice (Fig. 4b).  In addition, delivery of LFS (900 pulses at 1 Hz) generated a 
similar amount of LTD in WT and GluA1C2KI/GluA2C1KI mice in both field (Fig. 4c) and whole cell 
recordings (Fig. 4d).  Therefore, the LTP deficit in GluA1C2KI mice and LTD deficit in GluA2C1KI mice 
were completely rescued to WT levels in the double CTD replacement mice.  These results confirm that 
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the CTDs are the sufficient domains of GluA1 and GluA2 for specifying LTP and LTD expression, 
respectively, revealing the dominant role of the CTDs in governing bidirectional synaptic plasticity. 
 
Impaired synaptic delivery and removal of AMPARs in GluA1C2KI and GluA2C1KI mice, 
respectively  
To further elucidate the mechanisms underlying the LTP and LTD deficits in GluA1C2KI and GluA2C1KI 
mice, we examined the trafficking behavior of AMPARs.  First, we examined dendritic spines and 
surface AMPARs in cultured hippocampal neurons under basal conditions.  As shown in 
Supplementary Fig. S5a-c, no differences were found in either spine density or spine length between 
WT, GluA1C2KI and GluA2C1KI mice.  The level of basal surface (Supplementary Fig. S5d,e) and total 
AMPARs (Supplementary Fig. S5f) also showed no differences between WT and GluA1C2KI neurons.  
The amount of basal surface AMPARs assessed using an antibody directed to the CTD of GluA2 
(Supplementary Fig. S5d,e) was lower in GluA2C1KI neurons although total AMPARs in these neurons 
were similar to WT (Supplementary Fig. S5f).  The total amount of the presynaptic marker 
synaptophysin was not altered in either GluA1C2KI or GluA2C1KI neurons (Supplementary Fig. S5g). 
     To examine the activity-dependent AMPAR surface/synaptic delivery, we analyzed the amount of 
total surface and synaptic GluA2 with or without glycine treatment (200 M, 3 min), a protocol known 
to induce AMPAR surface insertion in cultured hippocampal neurons33.  In WT neurons, glycine 
treatment resulted in a significant increase in both total surface and synaptic GluA2 and these glycine-
induced changes in GluA2 were blocked by AP5 (Fig. 5a,d).  However, in neurons from GluA1C2KI 
neurons, glycine treatment did not affect either total surface or synaptic GluA2 (Fig. 5b,e).  In contrast 
to GluA1C2KI neurons, glycine treatment of GluA2C1KI neurons induced a significant increase in both 
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total surface and synaptic GluA2 (Fig. 5c,f), similar to WT neurons.  Therefore, the activity-dependent 
AMPAR insertion induced by glycine is defective in GluA1C2KI, but not in GluA2C1KI, neurons. 
     To examine the activity-dependent AMPAR removal from the synapse, we treated cultured 
hippocampal neurons with NMDA (25 M, 3 min) to trigger endocytosis of AMPARs.  As shown in 
Fig. 5g,j, NMDA treatment resulted in a significant decrease in both total surface and synaptic GluA2 
and this NMDA-induced decrease in GluA2 was blocked by AP5.  In GluA1C2KI neurons, NMDA 
treatment induced a similar decrease in both total surface and synaptic GluA2, which was also 
dependent on activation of NMDARs (Fig. 5h,k).  However, in GluA2C1KI neurons, NMDA treatment 
did not trigger any changes in either total surface or synaptic GluA2 (Fig. 5i,l).  Therefore, GluA2C1KI, 
but not GluA1C2KI neurons, are defective in NMDA induced endocytosis of AMPARs.  
     To extend the results from cultured neurons to a more physiological condition, we examined surface 
AMPARs on acute hippocampal slice treated with glycine (200 M, 3 min) or NMDA (25 M, 3 min).  
First, we performed biotinylation experiments to examine total surface AMPARs.  As shown in Fig. 6a-f 
and Supplementary Fig. S8, glycine induced an increase in surface GluA2 in WT and GluA2C1KI, but 
not in GluA1C2KI slices, whereas NMDA induced a decrease in surface GluA2 in WT and GluA1C2KI, but 
not in GluA2C1KI slices.  To further determine whether synaptic AMPARs were affected in a similar 
fashion, we conducted immunohistochemical staining of fixed hippocampal slices after the treatment.  
As shown in Fig. 6g-m, similar results were obtained, that is, glycine treatment caused an increase in 
both total surface and synaptic GluA2 in WT and GluA2C1KI, but not in GluA1C2KI slices, whereas 
NMDA treatment resulted in a decrease in total surface and synaptic GluA2 in WT and GluA1C2KI, but 
not in GluA2C1KI slices. 
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     Taken together these results are consistent with the hypothesis that the CTDs of GluA1 and GluA2 
are essential for activity-dependent AMPAR trafficking and suggest that the LTP deficit in GluA1C2KI 
mice and the LTD deficit GluA2C1KI mice are caused by defective AMPAR delivery and removal, 
respectively.  
 
An increase in single channel conductance in WT and GluA2C1KI, but not in GluA1C2KI mice 
following LTP induction. 
To further investigate the mechanisms by which the CTDs impact LTP, we analyzed single channel 
conductance () of synaptic AMPARs.  Previous studies suggest that an increase in  occurs in some 
neurons undergoing LTP34, but the receptor subunits and domains involved are unknown.  Therefore, we 
performed whole cell recordings and estimated  before and after LTP induction (4 trains of 100 Hz 
with 10 s inter-train intervals) using peak-scaled, non-stationary fluctuation analysis34.  As shown in Fig. 
7a-c, LTP was induced in WT and GluA2C1KI, but not in GluA1C2KI mice, consistent with the results 
obtained from field potential recordings.  During baseline recordings, the averaged  showed no 
differences between genotypes (Fig. 7d-h), suggesting that the CTDs of GluA1 and GluA2 do not 
differentially impact  of synaptic AMPARs under basal conditions.  However, after LTP induction, WT 
and GluA2C1KI, but not GluA1C2KI neurons showed a significant increase in  compared to baseline (Fig. 
7d-h).  These results indicate that the CTD of GluA1, but not of GluA2, is required for an increased  
after LTP induction.  Other channel properties such as the rise and decay time of EPSCs were not altered 
after the LTP induction protocol in all three genotypes (Fig. 7i,j).  
 
Distinct deficits in spatial and fear memory in GluA1C2KI and GluA2C1KI mice  
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The generation of these new mice that have pronounced yet specific deficits in hippocampal LTP and 
LTD provides useful models for relating these forms of synaptic plasticity to learning and memory.  
First, we used an open-field test to assess locomotor activity.  The GluA1C2KI and GluA2C1KI mice were 
similar to WT mice on most measures, except that the GluA1C2KI mice were slightly more active 
(Supplementary Fig. S6a,b).  Second, we used an elevated plus maze to evaluate the emotional state 
and anxiety levels but found no significant differences between genotypes (Supplementary Fig. S6c,d). 
     To examine their cognitive performance, we first conducted the visible platform version of the 
Morris water maze (MWM) test (Supplementary Fig. S7a), and showed that WT, GluA1C2KI and 
GluA2C1KI mice performed equally well, suggesting that swim ability, motivation and visual acuity were 
comparable in WT, GluA1C2KI and GluA2C1KI mice.  To assess spatial learning and memory, we 
performed the hidden platform water maze test.  As shown in Fig. 8a, during the learning acquisition 
phase, although GluA2C1KI mice showed no differences from WT, the GluA1C2KI mice were significantly 
slower to learn the task.  To assess the memory, we carried out probe tests 2 h and 24 h after the 
training.  As shown in Fig. 8b (2 h) and Fig. 8c (24 h), both WT and GluA2C1KI mice, but not GluA1C2KI 
mice, spent significantly more time in the target zone compared to other zones.  Similar results were 
obtained when the target quadrant was analyzed (Supplementary Fig. 7b,c).  To determine whether the 
deficits in GluA1C2KI mice could be related to the differences in training paradigm, we modified the 
protocol by increasing the duration and intensity of the training, but found that GluA1C2KI mice were still 
impaired in both learning and memory tests (Fig. 8d-f; Supplementary Fig. 7d,e).  These results 
indicate that the CTD of GluA1, but not of GluA2, is critical for spatial learning and memory.  
     To assess contextual memory, we used the fear conditioning paradigm.  As shown in Fig. 8g, during 
the training session all three genotypes responded to electric foot shocks equally well.  During the 
contextual test carried out 2 h (Fig. 8h) or 24 h (Fig. 8i) after the training, GluA2C1KI mice, but not 
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GluA1C2KI mice, showed a significantly reduced freezing compared to the WT control.  In the following 
cued tests, all three genotypes showed similar freezing in response to the tone (Supplementary Fig. 
S7f,g), suggesting that the fear response to simple conditioning stimulus remains intact in these mice.  
The deficits in GluA2C1KI mice but not in GluA1C2KI mice in contextual fear conditioning was surprising 
because several previous studies have shown that both GluA1 and LTP are involved in fear contextual 
memory7,35-37.  We considered the possibility that the three-shock training might have been too strong to 
reveal an effect in GluA1C2KI mice.  We therefore decreased the numbers of electric foot shocks from 
three to two.  As shown in Fig. 8j-l, although GluA1C2KI showed reduced freezing at 2 h after the 
training, no difference was found at 24 h after the training compared to WT mice.  The GluA2C1KI mice 
remained impaired at both intervals.  Interestingly, in cued tests, GluA1C2KI mice showed some mild 
deficits (Supplementary Fig. S7h,i).  We also used another fear conditioning paradigm that is thought 
to be particularly sensitive to pre-training hippocampal damage38. In this version of the test, mice were 
pre-exposed to the conditioning chamber in the absence of any shocks for 4 min. The next day, mice 
were placed back in the chamber and immediately received shocks. The mice were then tested 24 h later 
for a freezing responses.  As shown in Fig. 8m, the GluA2C1KI, but not GluA1C2KI mice showed 
significant impairments.  These results indicate that the CTD of GluA2 is likely more important than, 
but do not exclude a role for, the CTD of GluA1 in contextual fear memory. 
 
DISCUSSION 
In this study, we have created new mouse strains where the CTDs of the endogenous AMPARs are 
switched.  These mice have allowed us, for the first time, to address the in vivo role of the  CTDs of 
AMPARs in LTP and LTD without affecting the formation of heteromeric receptor complexes, their ion 
channel properties or basal synaptic strength.  We reveal that the CTDs of GluA1 and GluA2 are 
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necessary and sufficient for NMDAR-LTP and LTD, respectively, and confer specific effects on distinct 
forms of learning and memory. 
 
Unlike the traditional GluA mouse models, which are defective in both AMPAR expression and 
properties9,10,19-21,23, GluA1C2KI or GluA2C1KI mice exhibit little changes in these parameters.  The 
interpretation is that the CTD replacements have no effects on receptor expression or assembly, allowing 
the formation of physiologically normal, heteromeric AMPARs.  These results are consistent with in 
vitro studies showing that GluA1 or GluA2 homomers are defective in receptor assembly and ER exit 
and this is mediated by the extracellular N-terminal domain (NTD) and transmembrane Q/R segment of 
the receptor22.  Thus, the unique features of the CTD specific to GluA1 or of GluA2 do not appear to 
differentially impact the channel properties of AMPARs or synaptic strength under basal conditions.  It 
is interesting to note however, that although basal synaptic responses are not altered, the level of total 
surface GluA2 is lower in GluA2C1KI neurons.  One possibility is that GluA2C1KI receptors may behave 
more like GluA1 in terms of regulated membrane recycling leading to accumulation in recycling 
endosomes, which could explain lower basal surface levels as well as enhanced LTP in these mice.   
Previous studies using exogenously expressed mutant subunits in cultured hippocampal slices have 
suggested that the CTD of GluA1, but not of GluA2, is critical for LTP expression5-7,12,13.  However, this 
approach has been questioned due to the abnormally high level of the recombinant receptors and the 
formation of non-physiological homomeric receptors.  In addition, these studies did not directly address 
the role of native AMPARs.  The use of GluA1C2KI and GluA2C1KI mice overcomes these problems.  In 
GluA1C2KI, but not GluA2C1KI mice, LTP induced by HFS is absent confirming, in a more direct manner, 
that the CTD of GluA1, but not of GluA2, is essential for this form of LTP.  The lack of LTP in 
GluA1C2KI mice is not likely due to the inadequate activation of NMDARs during the induction phase 
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because the expression of NMDARs and their channel properties are unaltered in these mice.  The 
observations that both the activity-dependent synaptic delivery and an increase in single channel 
conductance of AMPARs are impaired in GluA1C2KI, but not GluA2C1KI mice, support the idea that 
direct modifications of AMPARs underlie LTP expression.  Our results are consistent with fact that the 
CTD of GluA1 contains motifs for phosphorylation (e.g., Ser831 and Ser845) and protein-protein 
interactions, both of which play critical roles in AMPAR trafficking and modifications of channel 
conductance39.  Previous studies have shown that GluA1 KO mice are impaired in LTP10,20, but this 
effect is complicated by the formation of the non-physiological receptors and a reduction in the surface 
AMPARs9,10,23.  It is interesting to note that LTP is intact or only mildly affected in mice with an altered 
PDZ domain28 or phosphorylation sites (Ser831 and Ser845) at the CTD of GluA127, suggesting that 
there are multiple, independent mechanisms operating within this domain and their combined action 
may be necessary for the full expression of LTP.  Consistent with this, there are numerous additional 
post-translational modification sites identified at the CTD of GluA139.   
 
In GluA2C1KI, but not in GluA1C2KI mice, LTD induced by LFS is absent, indicating that the CTD of 
GluA2, but not of GluA1, is essential for LTD.  Although the involvement of GluA2 in LTD has been 
previously suggested using peptides targeting the GluA2 CTD protein interactions14-18,40, the potential 
off-target effects of these peptides complicate the validity of the conclusion.  In addition, GluA2 KO or 
conditional mutant mice lacking all major AMPAR subunits (GluA1-3) are capable of LTD 
expression11,19,21, apparently refuting the requirement for GluA2 in LTD.  However, these mouse models 
are also compromised by dramatic changes in basal synaptic function as well as AMPARs properties, 
particularly enhanced Ca2+ permeability.  Therefore, the use of GluA2C1KI mice that have no changes in 
these basal properties but complete absence of LTD conclusively establishes the indispensable role of 
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the CTD of GluA2 in LTD.  The fact that NMDA-induced AMPAR removal from the synapse is 
impaired in these mice strongly supports that the CTD of GluA2 enables LTD through activity-
dependent endocytosis of AMPARs.  It is intriguing to note that although NMDAR-LTD is absent in 
GluA2C1KI mice, mGluR-LTD remains intact in both GluA2C1KI and GluA1C2KI mice, suggesting that 
mGluR-LTD is independent of the CTDs of GluA1 or GluA2.  Previous studies have shown that 
although the induction mechanisms of mGluR-LTD and NMDAR-LTP are different, the expression of 
both forms of LTD requires, at least in part, the removal of AMPARs from the synapse30,31.  Therefore, 
different domains of AMPARs must be involved in mGluR-LTD. 
 
Another key finding of this study is that the CTDs of GluA1 and GluA2 are not only necessary, but also 
sufficient domains within AMPARs for determining the directionality of synaptic plasticity.  Although 
the CTDs of AMPARs have been extensively investigated, none of the previous studies were able to 
address whether these domains can exert dominant effects over the rest of the receptor.  Our results that 
both LTP and LTD are restored in the CTD swapped mutant mice, indicating that the CTDs of GluA1 
and GluA2 can confer their specific effects on LTP and LTD, respectively, regardless of whether they 
are a part of GluA1 or GluA2.  However, this does not mean that the CTD of AMPARs alone is 
sufficient for LTP or LTP expression.   
 
Finally, our results have revealed that the CTDs of GluA1 and GluA2 play distinct roles in learning and 
memory.  Previous studies have shown that GluA1 KO or KI mice are not impaired in either learning 
acquisition or reference memory20,27,41,42, but it is possible that the altered basal transmission in these 
mice may have caused functional compensations.  It is also of concern that these previous mouse models 
have a hybrid genetic background, which could affect the behavioral performance.  In the case of GluA2 
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KO mice, learning and memory tests have not been possible due to their growth retardation and motor 
deficits19,29.  The GluA1C2KI and GluA2C1KI mice, which do not have these caveats, allow learning 
processes to be addressed more definitively.  In the water maze test, both learning acquisition and 
memory are impaired in GluA1C2KI, but not GluA2C1KI mice.  These impairments are not likely related to 
training procedures because longer training does not mitigate the deficits.  Therefore, the present study 
provides strong evidence for a critical role of native GluA1 in spatial learning and memory, and is 
consistent with a role for GluA1-dependent LTP in this form of memory.  Compared to spatial 
performance, contextual fear memory, as assessed by several different paradigms, is less affected in 
GluA1C2KI mice.  These results appear inconsistent with previous studies demonstrating the involvement 
of LTP in fear memory7,35-37 and suggest a dissociation between spatial and contextual fear memory.  It 
is possible however that when hippocampal LTP is impaired, other brain regions43 may compensate and 
enable contextual, but not spatial learning, because the latter is more demanding and requires a precise 
memory of the platform location.  Previous studies have indeed shown that hippocampal damage prior to 
training, which is in principle similar to the current genetic manipulations, impairs spatial learning in the 
water maze44, but has only mild effects on contextual fear learning45,46.  Damage to the parahippocampal 
regions (e.g., entorhinal cortex) impairs contextual, but not spatial learning47, suggesting that 
corticohippocampal circuits are differentially involved in spatial and contextual memories.  Therefore, it 
would be interesting to investigate LTP in extra-hippocampal brain regions in GluA1C2KI mice.  Another 
interesting finding of the study is that, in clear contrast to GluA1C2KI mice, GluA2C1KI mice are impaired 
in contextual, but not spatial performance, suggesting a role for LTD in fear memory.  A previous study 
shows that KO mice deficient in Bax, a member of the Bcl-2 family involved in apoptotic cell death, are 
impaired in hippocampal LTD and fear memory, but these mice also suffer from other behavioral 
deficits that undermine a link between the fear memory and LTD deficit48.  Our results that GluA2C1K 
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mice are impaired in NMDAR-LTD and contextual fear memory without other behavioral deficits, 
strongly support a role for NMDAR-LTD in this form of memory.  Thus, LTP and LTD differentially 
contribute to spatial and contextual memory. 
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Figure Legend: 
Fig. 1. Basal synaptic and AMPAR properties in GluA1C2KI and GluA2C1KI mice. 
(a) Amino acid sequences of the CTDs of GluA1 and GluA2 that are replaced or swapped in GluA1C2KI, 
GluA2C1KI and GluA1C2KI/GluA2C1KI mice.  (b) Predicted AMPAR subunit composition in WT, 
GluA1C2KI, GluA2C1KI and GluA1C2KI/GluA2C1KI mice.  In GluA1C2KI mice, the CTD of GluA1 is 
replaced by that of GluA2; in GluA2C1KI mice, the CTD of GluA2 is replaced by that of GluA1; in 
GluA1C2KI/GluA2C1KI double mutant mice, the CTD of GluA1 and GluA2 is swapped.  (c) Normal 
input/output curve of fEPSPs in GluA1C2KI mice (at 0.1 mA stimulus: WTpre = 0.00 ± 0.01 mV, WTfEPSP 
= 0.13 ± 0.02 mV, GluA1C2KIpre = 0.00 ± 0.02 mV, GluA1
C2KI
fEPSP = 0.14 ± 0.03 mV; at 0.2 mA 
stimulus: WTpre = 0.03 ± 0.02 mV, WTfEPSP = 0.30 ± 0.05 mV, GluA1
C2KIpre = 0.04 ± 0.02 mV, 
GluA1C2KIfEPSP = 0.36 ± 0.09 mV; at 0.3 mA stimulus: WTpre = 0.09 ± 0.02 mV, WTfEPSP = 0.61 ± 0.10 
mV, GluA1C2KIpre = 0.13 ± 0.03 mV, GluA1C2KIfEPSP = 0.71 ± 0.15 mV; at 0.4 mA stimulus: WTpre = 
0.15 ± 0.03 mV, WTfEPSP = 0.83 ± 0.11 mV, GluA1
C2KIpre = 0.20 ± 0.04 mV, GluA1C2KIfEPSP = 0.89 ± 
0.16 mV. WT: n = 7 slices from 4 mice; GluA1C2KI: n = 7 slices from 4 mice). Scale bar: 0.5 mV/20 ms.  
22 
 
(d) Normal input/output curve of fEPSPs in GluA2C1KI mice (at 0.1 mA stimulus: WTpre = 0.04 ± 0.00 
mV, WTfEPSP = 0.13 ± 0.03 mV, GluA2
C1KIpre = 0.03 ± 0.00 mV, GluA2C1KIfEPSP = 0.10 ± 0.02 mV; at 
0.2 mA stimulus, WTpre = 0.10 ± 0.02 mV, WTfEPSP = 0.28 ± 0.06 mV, GluA2
C1KIpre = 0.06 ± 0.01 mV, 
GluA2C1KIfEPSP = 0.22 ± 0.03 mV; at 0.3 mA stimulus: WTpre = 0.16 ± 0.04 mV, WTfEPSP = 0.51 ± 0.07 
mV, GluA2C1KIpre = 0.09 ± 0.02 mV, GluA2
C1KI
fEPSP = 0.37 ± 0.05 mV; at 0.4 mA stimulus: WTpre = 
0.24 ± 0.04 mV, WTfEPSP = 0.69 ± 0.08 mV, GluA2
C1KIpre = 0.15 ± 0.02 mV, GluA2C1KIfEPSP = 0.49 ± 
0.05 mV; WT: n = 9 slices from 5 mice; GluA2C1KI: n = 9 slices from 5 mice) Scale bar: 0.5 mV/20 ms.  
(e) EPSCNMDAR/EPSCAMPAR ratio in WT (0.83 ± 0.07, n = 23 neurons from 9 mice), GluA1
C2KI (0.84 ± 
0.17, n = 15 neurons from 6 mice, p = 0.910 compared to WT), GluA2C1KI (0.96 ± 0.14, n = 10 neurons 
from 6 mice, p = 0.550 compared to WT) and GluA2 KO mice (1.83 ± 0.26, n = 13 neurons from 6 
mice, ***p = 0.0001 compared to WT; F(3,57) = 8.751, p = 0.0000726).  Scale bar: 50 pA/25 ms.  (f) 
Sample traces and summary graphs of whole-cell patch-clamp recordings of mEPSCs of CA1 neurons 
showing no differences in either frequency (WT = 0.41 ± 0.06 Hz, n = 23 neurons from 14 mice; A1C2KI 
= 0.35 ± 0.08 Hz, n = 13 neurons from 7 mice; A2C1KI = 0.38 ± 0.08 Hz, n = 11 neurons from 7 mice; 
F(2, 44) = 0.147, p = 0.863) or amplitude (WT = 14.65 ± 0.49 pA, n = 23 from 14 mice; A1
C2KI = 13.25 ± 
0.38 pA, n = 13 neurons from 7 mice; A2CIKI = 14.65 ± 1.30 pA, n = 11 neurons from 7 mice; F(2, 44) = 
1.224, p = 0.304) between genotypes.  Scale bar: 20 pA/1 s.  (g) Sample traces and summary graph of 
AMPAR-mediated currents recorded from outside-out patches of CA1 neurons evoked by application of 
1 mM glutamate (3 s) showing no differences between genotypes (WT = 367.88 ± 40.85 pA, n = 26 
neurons from 7 mice; A1C2KI = 377.01 ± 52.09 pA, n = 21 neurons from 6 mice; A2CIKI = 378.17 ± 62.82 
pA, n = 24 neurons from 6 mice; F(2, 68) = 0.012, p = 0.988).  Scale bar: 100 pA/5 s.  (h) Sample traces 
and summary graph of normalized EPSCAMPAR at various holding potentials showing similar I/V 
relationships in WT, GluA1C2KI and GluA2C1KI mice, as compared to a strongly rectified I/V curve in 
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GluA2 KO mice (WT:  n = 12 neurons from 7 mice; GluA1C2KI: n = 9 neurons from 5 mice; GluA2C1K: n 
= 13 neurons from 7 mice; GluA2 KO: n = 9 neurons from 5 mice).  Scale bar: 50 pA/25 ms.  (i) 
Rectification index of EPSCAMPAR in WT (0.88 ± 0.06, n = 12 neurons from 7 mice), GluA1
C2KI (0.78 ± 
0.10, n = 9 neurons from 5 mice, p = 0.257 compared to WT), GluA2C1KI (0.83 ± 0.04, n = 13 neurons 
from 7 mice, p = 0.538 compared WT) and GluA2 KO mice (0.36 ± 0.03, n = 9 neurons from 5 mice, 
***p = 0.0000009 compared to WT; F(3, 39) = 6.041, p = 0.002).  (j) Sample traces and summary graph 
of normalized EPSCNMDAR at various holding potentials showing similar I/V relationships in WT, 
GluA1C2KI and GluA2C1KI mice.  Scale bar: 100 pA/25 ms.  (k) Normal PPF in GluA1C2KI mice (between 
genotypes: F(1,13) = 2.594, p = 0.131; at 0.025 s: WT = 1.81 ± 0.04, GluA1
C2KI = 1.96 ± 0.06; at 0.05 s: 
WT = 1.80 ± 0.10, GluA1C2KI = 1.93 ± 0.05; at 0.1 s: WT = 1.73 ± 0.08, GluA1C2KI = 1.86 ± 0.05; at 0.2 
s: WT = 1.51 ± 0.06, GluA1C2KI = 1.60 ± 0.04; at 0.5 s: WT = 1.25 ± 0.02, GluA1C2KI = 1.24 ± 0.04; at 1 
s: WT = 1.12 ± 0.02, GluA1C2KI = 1.15 ± 0.02. WT: n = 7 slices from 7 mice, GluA1C2KI: n = 8 slices 
from 8 mice).  (l) Normal PPF in GluA2C1KI mice (between genotypes: F(1,13) = 0.094, p = 0.764; at 0.025 
s: WT = 1.89 ± 0.10, GluA2C1KI = 1.87 ± 0.11; at 0.05 s: WT = 1.86 ± 0.10, GluA2C1KI = 1.85 ± 0.11; at 
0.1 s: WT = 1.81 ± 0.08, GluA2C1KI = 1.85 ± 0.10; at 0.2 s: WT = 1.54 ± 0.04, GluA2C1KI = 1.55 ± 0.06; 
at 0.5 s: WT = 1.21 ± 0.05, GluA2C1KI = 1.27 ± 0.05; at 1 s: WT = 1.08 ± 0.03, GluA2C1KI = 1.17 ± 0.04.  
WT: n = 7 slices from 7 mice, GluA2C1KI: n = 8 slices from 8 mice).  One-way ANOVA followed by 
post-hoc Fisher’s LSD multiple comparison test for Fig.1e, f, g and i; repeated two-way ANOVA test 
for Fig.1k,l. Data were presented as mean ± SEM. ***p < 0.001. 
 
Fig. 2. Absence of NMDAR-LTP, but intact NMDAR-LTD in GluA1C2KI mice. 
(a) Absence of LTP induced by HFS (100Hz, 1s) in GluA1C2KI mice (WT = 120.00 ± 3.21%, n = 5 slices 
from 5 mice ; A1C2KI = 99.98 ± 3.26%, n = 5 slices from 5 mice; t(8) = 3.092, **p = 0.002).  (b) 
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Absence of LTP induced by 4 compressed trains of HFS (with 10 s inter-train intervals) in GluA1C2KI 
mice (WT = 152.63 ± 13.79%, n = 5 slices from 5 mice; A1C2KI = 108.88 ± 4.44%, n = 6 slices from 6 
mice; t(9) = 3.267, **p = 0.010).  (c) Absence of LTP induced by 4 spaced trains of HFS (with 5 min 
inter-train intervals) in GluA1C2KI mice (WT = 138.94 ± 6.74%, n = 7 slices from 7 mice; A1C2KI = 
106.47 ± 7.50%, n = 7 slices from 7 mice; t(12) = 3.220, **p = 0.007).  (d) NMDAR-dependence of 
LTP induced by HSF in WT mice (WT = 163.64 ± 9.80%, n = 5 slices from 5 mice; WT+AP5= 92.08 ± 
4.52, n = 5 slices from 5 mice; t(8) = 6.629, ***p = 0.0002).  (e) Intact LTD in whole cell recordings in 
GluA1C2KI mice (WT = 55.51 ± 6.22%, n = 4 slices from 4 mice; A1C2KI = 60.26 ± 4.74%, n = 6 slices 
from 6 mice; t(8) = -0.618, p = 0.554).  (f) NMDAR-dependence of LTD induced by LFS in WT and 
GluA1C2KI mice (WT = 105.33 ± 5.97%, n = 5 slices from 5 mice; A1C2KI = 100.33 ± 9.87%, n = 5 slices 
from 5 mice; t(8) = 0.434, p = 0.676).  (g) Lack of effect of MPEP on LTD induced by LFS in WT and 
GluA1C2KI mice (WT = 65.45 ± 8.43%, n = 4 slices from 4 mice; A1C2KI = 52.50 ± 3.74%, n = 5 slices 
from 5 mice; t(7) = 1.518, p = 0.173).  Two tailed t-test at 95% confidence interval was used for all bar 
graphs. Data were presented as mean ± SEM. **p < 0.01, ***p < 0.001. Scale bar: 0.25 mV/25 ms for 
Fig. 2a-d and 50 pA/25 ms for Fig. 2e-f.  
 
Fig. 3. Absence of NMDAR-LTD, but intact mGluR-LTD in GluA2C1KI mice.  
(a) Absence of LTD induced by LFS in fEPSP recordings in GluA2C1KI mice (WT = 70.08 ± 3.61%, n = 
9 slices from 9 mice; A2C1KI = 102.33 ± 9.38%, n = 9 slices from 9 mice; t(16) = -3.210, **p = 0.005).  
(b) Absence of LTD induced by LFS in whole cell recordings in GluA2C1KI mice (WT = 57.04 ± 4.14%, 
n = 7 slices from 7 mice; A2C1KI = 95.02 ± 4.77%, n = 7 slices from 7 mice; t(12) = -6.015, ***p = 
0.0001).  (c) NMDAR-dependence of LTD induced by LFS (WT = 87.88 ± 9.89%, n = 5 slices from 5 
mice; A2C1KI = 98.97 ± 6.68%, n = 4 slices from 4 mice; t(7) = 0.876, p = 0.410).  (d) Lack of effect of 
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MPEP on LTD induced by LFS (WT = 62.06 ± 2.59%, n = 5 slices from 5 mice; A2C1KI = 94.26 ± 
8.47%, n = 4 slices from 4 mice; t(7) = 4.027, **p = 0.005).  (e) Enhanced LTP (4 compressed trains of 
HFS, with 10 s inter-train intervals) in GluA2C1KI mice (WT = 145.73 ± 5.04%, n = 5 slices from 5 mice; 
A2C1KI = 196.41 ± 22.27%, n = 6 slices from 6 mice; t(9) = -0.024, p = 0.074).  (f) NMDAR-dependence 
of LTP in WT and GluA2C1KI mice (WT+AP5 = 110.16 ± 6.94%, n = 5 slices from 5 mice; A2C1KI+AP5 
= 109.89 ± 8.59%, n = 5 slices from 5 mice; t(8) = 0.025, p = 0.981).  (g) Intact PP-LFS-induced LTD in 
GluA2C1KI mice (WT = 57.55 ± 7.70%, n = 7 slices from 7 mice; A2C1KI = 54.98 ± 7.42%, n = 8 slices 
from 8 mice; t(13) = 0.240, p = 0.814).  (h) Intact DHPG-induced LTD in GluA2C1KI mice (WT = 61.56 
± 2.80%, n = 5 slices from 5 mice; A2C1KI = 59.87 ± 3.47%, n = 5 slices from 5 mice; t(8) = 0.379, p = 
0.715).  Two tailed t-test at 95% confidence interval was used for all bar graphs. Data were presented as 
mean ± SEM. **p < 0.01, ***p < 0.001. Scale bar: 0.25 mV/25 ms for Fig. 3a, e and f, and 50 pA/25 ms 
for Fig. 3b-d, g and h.  
 
Fig. 4. Restoration of both LTP and LTD in GluA1C2KI/GluA2C1KI double CTD replacement mice. 
(a) Similar LTP induced by one train of HFS in WT and GluA1C2KI/GluA2C1KI mice (WT = 117.54 ± 
4.43%, n = 5 slices from 5 mice; A1C2KI/A2C1KI = 126.01 ± 6.85%, n = 5 slices from 5 mice; , t(8) = 
1.037, p = 0.330).  (b) Similar LTP induced by 4 trains of HFS (with 10 s inter-train intervals) in WT 
and GluA1C2KI/GluA2C1KI mice (WT = 160.69 ± 10.21%, n = 4 slices from 4 mice; A1C2KI/A2C1KI = 
154.11 ± 15.00%, n = 5 slices from 5 mice; t(7) = 0.342, p = 0.742).  (c) Similar LTD induced by LFS in 
field potential recordings in WT and GluA1C2KI/GluA2C1KI mice (WT = 76.44 ± 4.04%, n = 5 slices from 
5 mice; A1C2KI/A2C1KI = 72.92 ± 5.03%, n = 6 slices from 6 mice; t(9) = 0.529, p = 0.609).  (d) Similar 
LTD induced by LFS in whole cell recordings in WT and GluA1C2KI/GluA2C1KI mice (WT = 57.95 ± 
5.49%, n = 5 slices from 5 mice; A1C2KI/A2C1KI = 56.90 ± 7.17%, n = 5 slices from 5 mice; t(8) = 0.116, 
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p = 0.901).  Two tailed t-test at 95% confidence interval was used for all bar graphs.  Scale bar: 0.25 
mV/25 ms for Fig. 4a-c and 50 pA/25 ms for Fig. 4d. 
 
Fig. 5. Impaired Glycine and NMDA Induced AMPAR Surface Delivery and Removal in 
GluA1C2KI  and GluA2C1KI Cultured Neurons, Respectively.  
(a,b,c) Sample images of WT (a), GluA1C2KI (b) and GluA2C1KI (c) cultured hippocampal neurons 
treated with ACSF (Ctrl), glycine (Gly) or glycine plus AP5 (AP5+Gly) and stained for synaptophysin 
and surface GluA2 (GluA2-NTD).  (d) Summary graphs of normalized fluorescence intensities obtained 
from WT cultures (a) showing total surface GluA2 (Ctrl = 1.01 ± 0.04, n = 32 neurons; Gly = 1.31 ± 
0.05, n = 31 neurons; ***p = 0.000005 compared to Ctrl; AP5+Gly = 1.09 ± 0.04, n = 30 neurons, p = 
0.200 compared to Ctrl; F(2,90) = 12.673, p = 0.0000141) and synaptic GluA2 (Ctrl = 1.00 ± 0.09, n = 23 
neurons; Gly = 1.40 ± 0.13, n = 20 neurons, **p = 0.010 compared to Ctrl; AP5+Gly = 0.95 ± 0.10, n = 
18 neurons, p = 0.738 compared to Ctrl; F(2,58) = 5.080, p = 0.009).  (e) Summary graphs of normalized 
fluorescence intensities obtained from GluA1C2KI cultures (b) showing total surface GluA2 (Ctrl = 1.00 
± 0.04, n = 30 neurons; Gly = 1.01 ± 0.05, n = 31 neurons, p = 0.910 compared to Ctrl; AP5+Gly = 1.01 
± 0.05, n = 24 neurons, p = 0.861 compared to Ctrl; F(2,82) = 0.016, p = 0.984) and synaptic GluA2 (Ctrl 
= 1.00 ± 0.06, n = 20 neurons; Gly = 0.97 ± 0.09, n = 25 neurons, p = 0.813 compared to Ctrl; AP5+Gly 
= 0.85 ± 0.09, n = 19 neurons, p = 0.249 compared to Ctrl; F(2,61) = 0.768, p = 0.468).  (f) Summary 
graphs of normalized fluorescence intensities obtained from GluA2C1KI cultures (c) showing total surface 
GluA2 (Ctrl = 1.00 ± 0.046 n = 20 neurons; Gly = 1.45 ± 0.07, n = 19 neurons, ***p = 0.000004 
compared to Ctrl; AP5+Gly = 1.09 ± 0.08, n = 16 neurons, p = 0.353 compared to Ctrl; F(2,52) = 14.634, 
p = 0.00006) and synaptic GluA2 (Ctrl = 1.00 ± 0.07, n = 16 neurons; Gly = 1.80 ± 0.15, n = 16 neurons, 
***p = 0.00001 compared to Ctrl; AP5+Gly = 1.01 ± 0.12, n = 12 neurons, p = 0.945 compared to Ctrl; 
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F(2,41) = 15.767, p = 0.000083).  (g,h,i) Sample images of cultured WT (g), GluA1
C2KI (h) and GluA2C1KI 
(i) hippocampal neurons treated with ACSF (Ctrl), NMDA or NMDA plus AP5 (AP5+NMDA) and 
stained for surface GluA2 (GluA2-NTD) and synaptophysin.  (j) Summary graphs of normalized 
fluorescence intensities obtained from WT (g) showing total surface GluA2 (Ctrl = 1.00 ± 0.04, n = 31 
neurons; NMDA = 0.70 ± 0.05, n = 29 neurons; ***p = 0.000002 compared to Ctrl; AP5+NMDA = 0.92 
± 0.03, n = 11 neurons, p = 0.340 compared to Ctrl; F(2,68) = 13.920, p = 0.0000086) and synaptic GluA2 
(Ctrl = 1.00 ± 0.07, n = 15 neurons; NMDA = 0.54 ± 0.05, n = 11 neurons, ***p = 0.00002 compared to 
Ctrl; AP5+NMDA = 0.86 ± 0.08, n = 10 neurons, p = 0.158 compared to Ctrl; F(2,33) = 12.210, p = 
0.0001).  (k) Summary graphs of normalized fluorescence intensities obtained from GluA1C2KI (h) 
showing total surface GluA2 (Ctrl = 1.00 ± 0.07, n = 12 neurons; NMDA = 0.59 ± 0.09, n = 12 neurons, 
***p = 0.001 compared to Ctrl; AP5+NMDA = 1.00 ± 0.01, n = 10 neurons, p = 0.992 compared to Ctrl; 
F(2,31) = 8.049, p = 0.002) and synaptic GluA2 (Ctrl = 1.00 ± 0.12, n = 11 neurons; NMDA = 0.47 ± 
0.08, n = 12 neurons, **p = 0.001 compared to Ctrl; AP5+NMDA = 0.79 ± 0.12, n = 9 neurons, p = 
0.179 compared to Ctrl; F(2,29) = 7.209, p = 0.003).  (l) Summary graphs of normalized fluorescence 
intensities obtained from GluA2C1KI (i) showing total surface GluA2 (Ctrl = 1.02 ± 0.06, n = 29 neurons; 
NMDA = 1.15 ± 0.07, n = 27 neurons, p = 0.176 compared to Ctrl; AP5+NMDA = 1.10 ± 0.13, n = 12 
neurons, p = 0.541 compared to Ctrl; F(2,63) = 0.946, p = 0.394) and synaptic GluA2 (Ctrl = 1.00 ± 0.11, 
n = 13 neurons; NMDA = 0.87 ± 0.16, n = 10 neurons, p = 0.473 compared to Ctrl; AP5+NMDA = 0.93 
± 0.11, n = 12 neurons, p = 0.683 compared to Ctrl; F(2,32) = 0.268, p = 0.767).  n represented number of 
neurons from 3 independent cultures from each genotype.  One-way ANOVA followed by post-hoc 
Fisher’s LSD multiple comparison test was used for Fig. 5d-f, j-i.  Data were presented as mean ± SEM. 
**p < 0.01, ***p < 0.001. Scale bar: 20 m. 
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Fig. 6. Impaired Glycine and NMDA Induced AMPAR Surface Delivery and Removal in 
GluA1C2KI  and GluA2C1KI Hippocampal Slices, Respectively. 
(a,b,c) Sample blots of surface protein biotinylation experiments showing surface GluA2 in acute 
hippocampal slices treated with glycine (Gly), NMDA (NMDA) or ACSF (Ctrl).  (d) Summary graphs 
of normalized surface GluA2 in WT slices treated with Gly or NMDA compared to Ctrl (Gly: Ctrl = 
1.00 ± 0.00, Gly = 1.45 ± 0.15, n = 4 slices from 3 independent experiments; t(6) = -2.954, *p = 0.026; 
NMDA: Ctrl = 1.00 ± 0.00, NMDA = 0.62 ± 0.08, n = 8 slices from 3 independent experiments; t(14) = 
4.537, ***p = 0.0005).  (e) Summary graphs of normalized surface GluA2 in GluA1C2KI slices treated 
with Gly or NMDA compared to Ctrl (Gly: Ctrl = 1.00 ± 0.00, Gly = 1.06 ± 0.16, n = 6 slices from 3 
independent experiments; t(10) = -0.356, p = 0.729; NMDA: Ctrl = 1.00 ± 0.00, NMDA = 0.69 ± 0.13, n 
= 5 slices from 3 independent experiments; t(8) = 2.436, *p = 0.041). (f) Summary graphs of normalized 
surface GluA2 in GluA2C1KI slices treated with Gly or NMDA compared to Ctrl (Gly: Ctrl = 1.00 ± 0.00, 
Gly = 1.32 ± 0.09, n = 4 slices from 3 independent experiments; t(6) = -3.724, **p = 0.010; NMDA: Ctrl 
= 1.00 ± 0.00, NMDA = 1.08 ± 0.17, n = 6 slices from 3 independent experiments; t(10) = -0.456, p = 
0.658).  (g) Sample hippocampal section showing CA1 areas where immunofluorescence puncta were 
collected.  (h-j) Sample images of a selected CA1 area showing surface GluA2 (green) and 
synaptophysin (red) in WT (h), GluA1C2KI (i) and GluA2C1KI (j) hippocampal sections.  (k-m) Summary 
graphs of normalized total surface and synaptic GluA2 in WT (k) (Total surface GluA2: Ctrl = 1.00 ± 
0.02, n = 17 slices from 3 independent experiments; NMDA = 0.68 ± 0.09, n = 11 slices from 3 
independent experiments, ***p = 0.0003; Gly = 1.38 ± 0.09, n = 15 slices from 3 independent 
experiments, ***p = 0.0001; F(2, 40) = 23.704, p = 0.0000002.  Synaptic GluA2: Ctrl = 1.00 ± 0.06, n = 
16 slices from 3 independent experiments; NMDA = 0.41 ± 0.07, n = 11 slices from 3 independent 
experiments, ***p < 0.000001; Gly = 2.03 ± 0.47, n = 11 slices from 3 independent experiments, *p = 
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0.016; F(2, 35) = 9.955, p = 0.0003), GluA1
C2KI (l) (Total surface GluA2: Ctrl = 1.00 ± 0.05, n = 13 slices 
from 3 independent experiments; NMDA = 0.78 ± 0.05, n = 12 slices from 3 independent experiments, 
**p = 0.008; Gly = 0.88 ± 0.04, n = 11 slices from 3 independent experiments, p = 0.103; F(2, 33) = 4.951, 
p = 0.013. Synaptic GluA2: Ctrl = 1.00 ± 0.09, n = 12 slices from 3 independent experiments; NMDA = 
0.45 ± 0.15, n = 11 slices from 3 independent experiments, **p = 0.004; Gly = 0.91 ± 0.12, n = 8 slices 
from 3 independent experiments, p = 0.534; F(2, 28) = 6.159, p = 0.006) and GluA2
C1KI (m) (Total surface 
GluA2: Ctrl = 1.00 ± 0.03, n = 13 slices from 3 independent experiments; NMDA = 1.03 ± 0.12, n = 11 
slices from 3 independent experiments, p = 0.790; Gly = 1.37 ± 0.10, n = 11 slices from 3 independent 
experiments, **p = 0.001; F(2, 32) = 5.301, p = 0.10.  Synaptic GluA2: Ctrl = 1.00 ± 0.19, n = 13 slices 
from 3 independent experiments; NMDA = 1.04 ± 0.21, n = 11 slices from 3 independent experiments, p 
= 0.888; Gly = 3.71 ± 0.82, n = 10, **p = 0.002; F(2, 31) = 11.217, p = 0.000216) hippocampal sections.  
Two tailed t-test at 95% confidence interval was used for Fig. 6d-f and one-way ANOVA followed by 
two tailed t-test at 95% confidence interval for Fig.6k-m.  Data were presented as mean ± SEM. *p < 
0.05, **p < 0.01, ***p < 0.001. Scale bar: 200 m for Fig. 6g and 10 m for Fig. 6k-m.  See 
Supplementary Fig. S8 for full length Western blot scans. 
 
 
Fig. 7. An increase in single channel conductance of AMPARs in WT and GluA2C1KI following 
LTP induction. 
(a-c) Sample LTP recordings for peak scaled non-stationary fluctuation analysis in WT (a, repeated 8 
times with similar results), GluA1C2KI (b, repeated 8 times with similar results) and GluA2C1KI (c, 
repeated 7 time with similar results) mice showing absence of LTP in GluA1C2KI mice.  Scale bar: 
25pA/30ms.  (d-f) Representative EPSC traces and the conductance analysis in WT (d), GluA1C2KI (e) 
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and GluA2C1KI (f) mice before and after LTP induction (4 compressed trains of HFS, with 10 s inter-train 
intervals).  Top: representative mean traces from baseline (light) and LTP (dark) superimposed with 
individual sweeps (grey).  The carefully selected sweeps for analysis were aligned on the rise time 
phase, and scaled to the peak of their mean EPSC.  Bottom: corresponding current-variance relationships 
(solid and dashed lines indicate a parabolic fit for baseline and LTP, respectively). Scale bars: 
25pA/15ms.  (g) Increased mean single channel conductance in WT and GluA2C1KI, but not in 
GluA1C2KI mice after LTP induction (WT: γbaseline = 9.82 ± 2.01 pS, γLTP = 13.41 ± 1.70 pS, n = 8 
neurons from 8 mice, *p = 0.043; A1C2KI: γbaseline = 9.38 ± 1.67 pS, γLTP = 9.83 ± 2.26 pS, n = 8 neurons 
from 8 mice, p = 0.791; A2C1KI: γbaseline = 8.54 ± 1.75 pS, γLTP = 12.95 ± 1.47 pS, n = 7 neurons from 7 
mice, **p = 0.009).  (h) Rise time of EPSCs showing no changes after LTP induction in all genotypes 
(WT: baseline = 1.72 ± 0.11 ms, LTP = 1.80 ± 1.22 ms, n = 8 neurons from 8 mice, p = 0.986; A1C2KI: 
baseline = 1.33 ± 0.07 ms, LTP = 1.31 ± 0.10 ms, n = 8 neurons from 8 mice, p = 0.900; A2C1KI: 
baseline =1.88 ± 0.19 ms, LTP = 1.86 ± 0.21 ms, n = 7 neurons from 7 mice, p = 0.858).  (i) Decay time 
of EPSCs showing no changes after LTP induction in all genotypes (WT: baseline = 9.12 ± 0.56 ms, 
LTP = 9.66 ± 0.71 ms, n = 8 neurons from 8 mice, p = 0.149; A1C2KI: baseline = 8.29 ± 0.71 ms, LTP = 
8.31 ± 0.58 ms, n = 8 neurons from 8 mice, p = 0.947; A2C1KI: baseline =11.22 ± 0.88 ms, LTP = 10.81 
± 0.68 ms, n =7 neurons from 7 mice, p = 0.579).  Paired t-test at 95% confidence interval was used for 
Fig. 7g-i. Data were presented as mean ± SEM. *p<0.05, **p<0.01. 
 
Fig. 8. Spatial and contextual fear memory deficits in GluA1C2KI and GluA2C1KI mice. 
(a) Learning acquisition of the hidden platform water maze test showing that GluA1C2KI mice were 
slower to learn the location of the platform (between genotypes: WT: n = 11 mice, A1C2KI: n = 9 mice, 
A2C1KI: n = 11 mice; F(2, 28) = 7.318, **p = 0.003; day 5: WT = 40.79 ± 4.93s, A1
C2KI = 56.34 ± 2.89s, 
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A2C1KI = 48.11 ± 2.83s, F(2, 28) = 4.031, *p = 0.029; day 6: WT = 38.92 ± 4.70s, A1
C2KI = 53.20 ± 4.00s, 
A2C1KI = 32.29 ± 5.56s, F(2, 28) = 4.447, *p = 0.021; day 7: WT = 29.36 ± 5.79s, A1
C2KI = 54.39 ± 2.54s, 
A2C1KI = 35.29 ± 4.14s, F(2, 28) = 7,658, *p = 0.002).  On last training day 8, all three genotypes reached 
the platform equally well (WT = 29.48 ± 5.98s, A1C2KI = 45.47 ± 5.03s, A2C1KI = 35.67 ± 4.29s, F(2, 28) = 
2.292, p = 0.120).  (b) Probe test at 2 h after the last training session showing that both WT and 
GluA2C1KI mice, but not GluA1C2KI mice, spent significantly more time (seconds) swimming in the 
target zone (WT: target = 20.591 ± 3.034, other = 9.185 ± 0.852, n = 11 mice, t(10) = 3.127, *p = 0.011; 
A1C2KI: target = 8.94  ± 2.34, other = 8.07 ± 1.39, n = 9 mice, t(8) = 0.480, p = 0.644; A2
C1KI: target = 
17.04  ± 2.21, other = 10.68 ± 0.88, n = 11 mice, t(10) = 2.392, *p = 0.039) compared other zones.  (c) 
Probe test at 24 h after the last training session showing that both WT and GluA2C1KI mice, but not 
GluA1C2KI mice, spent significantly more time (seconds) swimming in the target zone (WT: target = 
18.40  ± 2.64, other = 9.71 ± 1.14, n = 11 mice, t(10) = 2.588, *p = 0.025; A1
C2KI: target = 8.14  ± 1.24, 
other = 7.93 ± 1.31, n = 9 mice, t(8) = -0.113, p = 0.912; A2
C1KI: target = 14.08 ± 1.54, other = 10.34 ± 
1.07, n = 11 mice, t(10) = 3.366, **p = 0.007) compared to other zones.  (d) Learning acquisition of 
hidden platform water maze with enhanced training showing slower learning in GluA1C2KI mice 
(between genotypes: WT: n = 9 mice, A1C2KI : n = 8 mice, A2C1KI: n = 8 mice, F(2, 22) = 6.662, **p = 
0.005; day 4: WT = 34.21 ± 3.17s, A1C2KI = 47.81 ± 3.96s, A2C1KI = 40.82 ± 3.98s, F(2, 22) = 3.464, *p = 
0.049; day 5: WT = 30.92 ± 3.78s, A1C2KI = 46.63 ± 4.20s, A2C1KI = 35.33 ± 2.80s, F(2, 22) = 4.902, *p = 
0.017; day 6: WT = 28.48 ± 6.72s, A1C2KI = 43.86 ± 7.94s, A2C1KI = 34.20 ± 7.55s, F(2, 22) = 1.118, p = 
0.345; day 7: WT = 32.91 ± 6.86s, A1C2KI = 40.30 ± 7.32s, A2C1KI = 25.08 ± 6.72s, (F(2, 22) = 1.142, p = 
0.337; day 8: WT = 21.09 ± 4.96s, A1C2KI = 36.63 ± 7.62s, A2C1KI = 24.31 ± 6.79s, (F(2, 22) = 1.611, p = 
0.222; day 9: WT = 19.79 ± 5.01s, A1C2KI = 35.75 ± 6.93s, A2C1KI = 24.35 ± 7.77s, (F(2, 22) = 1.573, p = 
0.230).  (e) Probe test at 2 h after the last training session showing impaired memory in GluA1C2KI mice 
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(WT: target = 14.67 ± 1.43, other = 3.82 ± 0.38, n = 9 mice, t(8) = 8.69, ***p = 0.00002; A1
C2KI: target = 
7.14  ± 1.39, other = 5.08 ± 0.79, n = 8 mice, t(7) = 1.480, p = 0.182; A2
C1KI: target = 17.51 ± 4.66, other 
= 3.06 ± 0.57, n = 8 mice, t(7) = 2.992, *p = 0.020).  (f) Probe test at 24 h after the training showing 
impaired memory in GluA1C2KI mice (WT: target = 13.12 ± 1.45, other = 3.43 ± 0.38, n = 9 mice, t(8) = 
7.804, ***p = 0.00005; A1C2KI: target = 10.06  ± 3.44, other = 5.69 ± 0.93, n = 8 mice, t(7) = 1.274, p = 
0.243; A2C1KI: target = 17.60  ± 3.44, other = 3.55 ± 0.79, n = 8 mice, , t(7) = 3.488, *p = 0.010).  (g) 
Freezing response (after the third foot shock) in response to three foot shocks in the conditioning 
chamber (WT: before = 2.55 ± 0.65%, after = 30.85 ± 4.29%, n = 12 mice, t(11) = -7.283, ***p = 
0.00002; A1C2KI: before = 2.18 ± 0.63%, after = 29.31 ± 4.38%, n = 12 mice, t(11) = -6.788, ***p = 
0.00003; A2C1KI: before = 5.61 ± 1.42%, after = 40.62 ± 3.21%, n = 12 mice, t(11) = -10.470, ***p = 
0.0000005).  (h) Contextual memory test at 2 h after conditioning (WT = 38.16 ± 5.57%, n = 12 mice; 
A1C2KI = 41.55 ± 5.92%, n = 12 mice, p = 0.681 compared to WT; A2C1KI = 20.43 ± 3.32%, n = 12, *p = 
0.012 compared to WT; F(2, 33) = 5.004, p = 0.013).  (i) Contextual memory test at 24 h after 
conditioning (WT = 35.47 ± 5.87%, n = 12 mice; A1C2KI = 43.03 ± 8.47%, n = 12 mice, p = 0.47 
compared to WT; A2C1KI = 21.61 ± 2.49%, n = 12 mice, *p = 0.041 compared to WT; F(2,33) = 5.00, p = 
0.013).  (j) Freezing response (after the second foot shock) in response to two foot shocks in the 
conditioning chamber (WT: before = 3.59 ± 1.23%, after = 35.66 ± 7.33%, n = 9 mice, **p = 0.002; 
A1C2KI: before = 1.52 ± 0.33%, after = 32.63 ± 6.89%, n = 8 mice, **p = 0.003; A2C1KI: before = 5.48 ± 
1.31%, after = 42.96 ± 7.46%, n = 9 mice, ***p = 0.001).  (k) Contextual memory test at 2 h after 
conditioning (WT = 33.00 ± 6.197%, n = 9 mice; A1C2KI = 18.62 ± 3.67%, n = 8 mice, *p = 0.040 
compared to WT; A2C1KI = 20.04 ± 3.19%, n = 9 mice, *p = 0.055 compared to WT; F(2, 23) = 2.982, p = 
0.071).  (l) Contextual memory test at 24 h after conditioning (WT = 33.29 ± 5.75%, n = 9 mice; A1C2KI 
= 30.41 ± 6.79%, n = 8 mice, p = 0.746 compared to WT; A2C1KI = 18.72 ± 3.57%, n = 9 mice, *p = 
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0.047 compared to WT; F(2, 23) = 2.077, p = 0.148).  (m) Contextual memory test on the third day 
following pre-exposure to the conditioning chamber without foot shocks on day 1 and two foot shocks 
on day 2 (WT = 32.21 ± 4.31%, n = 17 mice; A1C2KI = 32.86 ± 4.68%, n = 14 mice, p = 0.920 compared 
to WT; A2C1KI = 20.17 ± 2.79%, n = 17 mice, *p = 0.025 compared to WT; F(2, 45) = 3.372, p = 0.043). 
Paired t-test at 95% confidence interval was used for Fig. 8b,c,e,f,g, one-way ANOVA followed by 
post-hoc Fisher’s LSD multiple comparison test for Fig. 8h,i,k, one-way ANOVA followed by two 
tailed t-test at 95% confidence interval for Fig. 8l,m.  Data were presented as mean ± SEM. *p<0.05, 
**p<0.01,***p<0.001. 
 
 
Methods: 
 
Generation of GluA1C2KI mice 
The GluA1C2KI mouse model, where the C-terminal domain (CTD) of GluA1 
(EFCYKSRSESKRMKGFCLIPQQSINEAIRTSTLPRNSGAGASGGSGSGENGRVVSQDFPKSMQSI
PCMSHSSGMPLGATGL) is replaced by the CTD of GluA2 
(EFCYKSRAEAKRMKVAKNAQNINPSSSQNSQNFATYKEGYNVYGIESVKI), was generated by 
using standard homologous recombination techniques in embryonic stem (ES) cells as described 
previously (Fig. S1 and S2, ref 19,21,49) in collaboration with Biocytogen (Worcester, MA, USA).  
Briefly, a targeting vector was constructed (by using a BAC clone, Rp23-118D11, Invitrogen, isolated 
from a C57BL/6J mouse genomic library) in such a way that the C-terminus of GluA1 (81 AA) was 
replaced with the C-terminus of GluA2 (50 AA) using an overlap extension-PCR method.  The targeting 
vector contained a Frt-flanked Neo resistance positive selection marker inserted 315bp upstream of 
exon15, a number of new restrictions sites (i.e. EcoRI and VspI) used for diagnostic restriction 
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digestions to confirm the homologous recombination events and two homology arms (left: 4.6 kb; right: 
4.7 kb).  A DTA negative selection marker was inserted downstream of the right arm.  The vector was 
verified by sequencing the entire construct.  After linearization, the targeting vector was transfected into 
C57BL/6J-derived ES cells (Biocytogen Worcester, MA, USA) by electroporation (BTX, USA).  
Positive ES clones were identified first by long-range PCR screening methods (forward primer 1: 
ctgtgaacctggttcaagatcacac; reverse primer 1: cagaggccacttgtgtagcg; forward primer 2: 
gctcgactagagcttgcgga; reverse primer 2: gccttgctgatcataccttagcatc) and then confirmed by Southern 
blotting analysis with both 5’and 3’probes.  The 5’ and 3’ probes were obtained by PCR amplification 
from the C57BL/6J genomic DNA using following primers. 5’ probe (451bp) forward: 
gagcataggagaacagtgtcag, 5’ probe reverse: actggatgtctaattggactatgc; 3’ probe (412bp) forward: 
cacactgatgggcatgtcatc; 3’ probe reverse: ctgtgacttccactagcagg.  The confirmed ES clones were injected 
into Balb/c blastocysts and implanted into pseudopregnant females.  10 chimeric male mice were 
crossed with C57BL/6J females to obtain F1 mice carrying the recombinant allele containing the C-
terminus of GluA2 (50 AA) and Neo selection marker.  The resulting pups were bred for germline 
transmission of the recombination event by using PCR strategy.  Heterozygous males were then mated 
with the FLIP females to remove the Neo marker.  The FLIP mice have a pure C57BL/6J background 
(Jackson Laboratories).  Homozygous mutant mice were obtained by inter-crossing heterozygous 
littermates.  Because the ES cell line that we used for creating the GluA1C2KI mice was derived from the 
C57BL/6J mice, therefore, all the mice used for this study were of a pure C57BL/6J genetic background, 
eliminating a potential effect of variable genetic backgrounds on the phenotype of the mice.  The PCR 
primers used for mouse tail DNA genotyping included: WT forward: cagcaataccatcaatgaagaccatacg; WT 
reverse: gctgaattgccctccatatggttg; GluA1C2KI forward: gagttctgttacaagtcaagggcc (or 
ctttgtttttggcactgaagggc); GluA1C2KI reverse: gctgaattgccctccatatggttg; Frt forward: 
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gagacatgcacaatgatggaggc; Frt reverse: cttctctgggacaggagataccac.  All the GluA1C2KI mice used in this 
study were homozygous mice for the CTD replacement and their wild type littermate offspring from the 
heterozygous breeders. 
 
Generation of GluA2C1KI mice 
The GluA2C1KI mouse model, where the CTD of GluA2 
(EFCYKSRAEAKRMKVAKNAQNINPSSSQNSQNFATYKEGYNVYGIESVKI) is replaced by the 
CTD of GluA1 
(EFCYKSRSESKRMKGFCLIPQQSINEAIRTSTLPRNSGAGASGGSGSGENGRVVSQDFPK 
SMQSIPCMSHSSGMPLGATGL), was generated by using standard homologous recombination 
techniques in embryonic stem (ES) cells as described previously (Fig. S1 and S2, ref 19,21,49, in 
collaboration with Biocytogen (Worcester, MA, USA).  Briefly, a targeting vector was constructed (by 
using a BAC clone, RP23-409L22; Invitrogen, isolated from a C57BL/6J mouse genomic library) in 
such a way that the C-terminus of GluA2 (50 AA) was replaced with the C-terminus of GluA2 (81 AA) 
using an overlap extension-PCR method.  The targeting vector contained a Frt-flanked Neo resistance 
positive selection marker inserted 371bp upstream of exon15, a number of new restriction sites (i.e. 
XbaI and DraIII) used for diagnostic restriction digestions to confirm the homologous recombination 
events and two homology arms (left: 4.6 kb; right: 5.3 kb).  A DTA negative selection marker was 
inserted downstream of the right arm.  The vector was verified by sequencing the entire construct.  After 
linearization, the targeting vector was transfected into C57BL/6J-derived ES cells (Biocytogen, 
Worcester, MA, USA) by electroporation (BTX, USA). Positive ES clones were identified first by long-
range PCR screening methods (forward primer: gctcgactagagcttgcgga; reverse primer: 
actccctcccaagagtttaatccac) and then confirmed by Southern blotting analysis with both 5’and 3’probes.  
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The 5’ and 3’ probes were obtained by PCR amplification from the C57BL/6J genomic DNA using 
following primers. 5’ probe (364bp) forward: gaggtagcagacacacagac, 5’ probe reverse: 
gtggattgtctttgtgaaag; 3’ probe (337bp) forward: agtcttatctttgcccatcagg; 3’ probe reverse: 
aagctagagagctggacttga.  The confirmed positive ES clones were injected into Balb/c blastocysts and 
implanted into pseudopregnant females.  5 chimeric male mice were crossed with C57BL/6J females to 
obtain F1 mice carrying the recombinant allele containing the C-terminus of GluA1 (81 AA) and Neo 
selection cassette.  The resulting pups were bred for germline transmission of the recombination event 
by using the PCR strategy.  Heterozygous males were then mated with the FLIP females to remove the 
Neo cassette.  The FLIP mice have pure a C57BL/6J background (Jackson Laboratories).  Homozygous 
mutant mice were obtained by inter-crossing heterozygous littermates.  Because the ES cell line that we 
used for creating the GluA2C1KI mice was derived from the C57BL/6J mice, therefore, all the mice used 
for this study were of a pure C57BL/6J genetic background, eliminating a potential effect of variable 
genetic backgrounds on the phenotype of the mice.  The PCR primers used for mouse tail DNA 
genotyping included: WT forward: gttacaagtcaagggccgagg; WT reverse: gcaggttagtcactggtcagg; 
GluA2C1KI forward: ccctgcatgagccacagttc; GluA2C1KI reverse: gcaggttagtcactggtcagg; Frt forward: 
actgacactctgtcttaggaatct; Frt reverse: agctgaagaaatttggtggactc.  All the GluA2C1KI mice used in this study 
were homozygous mice for the CTD knock-in replacement and their wild type littermate offspring 
derived from the heterozygous breeders.  
 
Generation of GluA1C2KI/GluA2C1KI CTD double replacement mice 
To produce GluA1C2KI/GluA2C1KI mice (homozygous for both CTD replacements, i.e. the CTD of GluA1 
is replaced by that of GluA2 and the CTD of GluA2 is replaced by that of GluA1), the GluA1C2KI was 
first bred with GluA2C1KI to obtain heterozygous mice for both CTD replacements, which were 
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subsequently intercrossed to produce homozygous GluA1C2KI/GluA2C1KI mice (Fig. S1 and S2). 
 
Housing, maintenance and use of the mice 
Mice were group housed (2-5 mice per cage) on a 12h/12h light/dark cycle with food and water ad 
libitum.  All experimental procedures were conducted in accordance with the guidelines of the Canadian 
Council on Animal Care (CCAC) and approved by the Animal Care Committee at the Hospital for Sick 
Children, Canada and Southeast University, China.  All experiments were performed blind to the 
genotype of the mice, that is, the mice were coded by an independent investigator before the 
experimentation and decoded after the completion of the experiments for data grouping and analyses. 
All the data collection, animal assignment, drug treatment and experimental conditions were randomized 
with regard to the genotypes of the mice.  
 
Antibodies, chemicals and other reagents  
Primary and secondary antibodies include: Rabbit polyclonal anti-GluA1-CTD (Millipore, 
Cat#MAB2263), Rabbit polyclonal anti-GluA1-NTD (Cell signaling technology, Cat#T8850), Mouse 
monoclonal anti-GluA2-NTD (Millipore,Cat#MAB397), Rabbit polyclonal anti-GluA3 (Cell signaling 
technology, Cat#4676), Rabbit polyclonal anti-GluA4 (Cell signaling technology, Cat#T8030), Rabbit 
polyclonal anti-p-GluA1-831 (Santa Cruz, Cat#sc-16313 ), Rabbit polyclonal anti-p-GluA1-845 (Cell 
signaling technology, Cat#8084), Rabbit polyclonal anti-p-GluA2-Tyr (869/873/876) (Cell signaling 
technology, Cat#3921). Mouse monoclonal anti-MAP2 (Millipore, Cat#MAB3418), Rabbit polyclonal 
anti-NR1 (Millipore, Cat#AB9864), Rabbit polyclonal anti-NSF (Cell signaling technology, Cat#3924), 
Rabbit polyclonal anti-Pan-cadherin (Cell signaling technology, Cat#4068), Mouse monoclonal anti-
PSD95 (Millipore, Cat#MABN68), Rabbit polyclonal anti-SAP97 (Abcam, Cat#ab134156), Rabbit 
polyclonal anti-Synapsin1 (Bioworld, Cat#BS4116), Rabbit polyclonal anti-Synaptophysin (Cell 
38 
 
signaling technology, Cat#D35E4), Mouse monoclonal anti-Tubulin (Sigma-Aldrich, Cat#T9026), Goat 
anti-rabbit (Genscript, Cat#A00098), Goat anti-mouse (Genscript, Cat#A00160), Alexa Fluor 488 
donkey anti-mouse IgG (Thermo-Fisher, Cat#R37114), Alexa Fluor 555 goat anti-mouse IgG (Thermo-
Fisher, Cat#A-21422), Alexa Fluor 555 donkey anti-rabbit IgG (Thermo-Fisher, Cat#A-31570), Alexa 
Fluor 633 goat anti-mouse IgG (Thermo-Fisher, Cat#A-21050).  Drugs include: Picrotoxin (Sigma-
Aldrich, Cat#R284556), (RS)-3,5-DHPG (Tocris, Cat#0342), MPEP (Tocris, Cat#1212), D-AP5 
(Tocris, Cat#0106), Spermine (Sigma-Aldrich, Cat#55513), Tetrodotoxin (Sigma-Aldrich, Cat#A3109), 
Cyclothiazide (Tocris, Cat#0713), Neurobasal A (Thermo-Fisher, Cat#10888022), B27 (Thermo-Fisher, 
Cat#17504044), NMDA (Tocris, Cat#0114), NBQX (Sigma-Aldrich, Cat#N183), Biotin-XX, SSE 
(Thermo-Fisher, Cat#B6352), Rhodamine phalloidin (Thermo-Fisher, Cat#R415) DAPI (Cayman 
Chemical, Cat#28718-90-3), Poly-D-lysine (Sigma-Aldrich, Cat#P7280), GlutaMax (Thermo-Fisher, 
Cat#35050061), Diamond Antifade Mountant (Thermo-Fisher, Cat#P36965).  Streptavidin Trial Kit was 
purchased from Thermo-Fisher (Cat#65801D). 
 
Slice electrophysiology 
All the electrophysiological recordings were conducted at the Schaffer collateral - commissural pathway 
in the hippocampus as previously described19,21,49,50.  Briefly, the mouse brains were quickly removed 
and sagittal 360 µm hippocampal slices prepared in ice-cold artificial cerebrospinal fluid (ACSF) 
saturated with 95% O2/5% CO2. ACSF contained (in mM): 120.0 NaCl, 3.0 KCl, 1.2 MgSO4, 1.0 
NaH2PO4, 26.0 NaHCO3, 2.0 CaCl2, and 11.0 D-glucose.  The slices were recovered at 28 oC for at least 
2 hrs before a single slice was transferred to a submersion chamber perfused with 95% O2 / 5% CO2 
saturated ACSF with (for whole-cell recordings) or without (for field recordings) 100 µM picrotoxin.  
Perfusion flow rate was kept constant at 2 ml/min.  Hippocampal CA1 neurons were visualized using an 
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infrared differential interference contrast microscope (Zeiss Axioscope or Olympus X51).  Synaptic 
response was evoked at 0.067 Hz for field potentials and 0.1 Hz for whole-cell currents, and recorded 
with glass pipettes (3-4 MΩ) filled with either ACSF (for field) or the intracellular solution (for whole-
cell) containing (in mM) 130.0 CsMeSO4, 5.0 NaCl, 1 MgCl2, 0.05 EGTA, 10.0 HEPES, 3.0 Mg-ATP, 
0.3 Na3GTP, and 5.0 QX-314 (pH 7.5) (280-300 mOsm).  For field recordings, low-frequency 
stimulation (LFS, 900 pulses at 1 Hz) and paired-pulse (interval at 50 ms) low-frequency stimulation 
(PP-LFS, 900 paired pulses at 1 Hz) were used to induce NMDAR- and mGluR-LTD, respectively.  
LTP was induced by 1 or 4 trains of high-frequency stimulation (HFS, 100 Hz, 1 s) with an inter-train 
interval of 10 s or 5 min.  For input-output experiments, the stimulus intensity was increased gradually 
from 0.1 mA, 0.2 mA, 0.3 mA to 0.4 mA.  Paired-pulse facilitations were obtained at inter-pulse 
intervals of 25 ms, 50 ms, 100 ms, 200 ms, 500 ms or 1 s, and calculated as the ratios of the second 
response peak values over the first response peak values.  For LTD whole-cell experiments, cells were 
clamped at -65 mV throughout the recording except during LTD induction (LFS: 900 pulses at 5 Hz, at -
40 mV holding potential; PP-LFS: 600 paired pulses at1 Hz, at -65 mV holding potential).  DHPG-LTD 
was induced by bath application of 100 μM (RS)-3,5-DHPG for 10 mins.  The age of mice was 13-15 
days for LFS-LTD and non-SFA experiments and 3-4 weeks for PP-LFS-LTD, DHPG-LTD and all 
other LTP experiments.  LTP and LTD were calculated and statistically evaluated by comparing the 
mean values of the last 10 min of the recording and the mean values of the entire baseline.  For 
current/voltage (I/V) relationship and rectification index experiments, synaptic currents (5 responses at 
each holding potential) mediated by NMDARs (EPSCNMDAR) or AMPARs (EPSCAMPAR) were obtained 
for the following holding potentials (-80 mV, -60 mV, -40 mV, -20 mV, 0 mV, 20 mV, 40 mV, 60 mV), 
with 100 μM spermine and 50 μM D-AP5 (for EPSCAMPAR) or 10 μM NBQX (for EPSCNMDAR) added to 
the extracellular solution, respectively.  The responses were normalized to those obtained at -80 mV.  
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The rectification index of EPSCAMPAR was calculated by the ratio of the slopes of the line connecting 0 
to 60 mV and -60 to 0 mV.  For EPSCNMDAR/EPSCAMPAR ratio experiments, EPSCAMPAR was the peak 
value obtained at -70 mV, whereas EPSCNMDAR was the response amplitude at +40 mV taken 40 ms after 
the onset of the response.  For miniature EPSCs (mEPSCs), the responses were recorded at -70 mV in 
the presence of the 100 μM picrotoxin and 1 μM TTX.  In all of the whole-cell recordings, cell series 
resistance was monitored throughout experiments by applying a -3 mV step at the end of each response 
sweep and the experiment was excluded from analysis if the resistance changed by more than 20%.  For 
the outside-out patch experiments, after the whole-cell patch clamp mode was obtained from the CA1 
neuron at -70 mV, the patch pipette (4-7 MΩ) was slowly pulled away from the soma until a high-
resistance seal was reformed.  AMPAR-mediated currents of the patch were evoked by a fast puff 
delivered from a pipette (3-5 MΩ) filled with ACSF containing 100 μM picrotoxin, 50 μM D-AP5, 100 
μM cyclothiazide, 1 μM TTX and 1 mM L-glutamate acid monosodium salt monohydrate using the 
PV830 Pneumatic Picopump (WPI).  All recording data acquisition and analysis were done using the 
pCLAMP 10.2 (Axon Instruments) and MiniAnalysis program (Synaptosoft).  n in all recording figures 
represents the number of slices/neurons and at most two slices/neurons from each animal were used. 
 
Peak-scaled, non-stationary fluctuation analysis 
The single channel conductance () of synaptic AMPARs in WT and mutant mice was estimated using 
peak-scaled non-stationary fluctuation analysis (ps-NSFA) as described previously34.  Neurons were 
clamped at -70 mV and whole-cell EPSCs were strictly selected using WinLTP and Mini Analysis 
software based on the following criteria: (1) precise alignment of responses on the rising phase of 
EPSCs; (2) no contamination by spontaneous or polysynaptic currents; and (3) complete decay from the 
peak EPSCs.  The variance of fluctuation of the decay was analyzed and plotted against the mean 
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amplitude of EPSCs.  The single channel conductance was calculated by fitting the plot to a second 
polynomial equation, σ2 = iI - I2/N + b1, where σ2 is the variance, I is the mean current, N is the number 
of channels activated, i is the single channel current and b1 is the background noise.  For the conductance 
conversion (i.e.  = i/V), the driving force (V) was set to -70 mV.  LTP was induced by HFS (100 Hz, 1 s 
delivered 4 trains with an inter-train interval of 10 s) in current-clamp mode.  The kinetics of EPSCs 
were calculated by measuring the 20-80% rise time (τrise) and 62% decay time (τdecay), respectively, 
using the Clampfit. 
 
Immunohistochemistry of brain sections 
The procedures for brain processing and immunohistochemistry were described previously21,49.  Briefly, 
mice were anesthetized by 10% chloral hydrate and subjected to cardiac perfusion with 0.1 M 
phosphate-buffered saline (PBS) followed by 4% paraformaldehyde (PFA in PBS).  The brain was then 
dissected and further fixed in 4% PFA for an additional 24 h, and then transferred to 30% sucrose in PBS 
solution till it was saturated. The brain was embedded in Tissue-Tek® O.C.T. compound, frozen in 
liquid nitrogen and stored at - 80 °C, before being sliced to 25 μm coronal crystat sections at -20 °C 
(Leica CM1950).  The brain sections were transferred to a glass slide coated with poly-D-lysine for 
immunostaining.  Sections were washed with PBS, permeabilized by 0.1% Triton X-100 in PBS for 2 h, 
blocked with 10% fetal bovine serum for 1 h, and incubated with primary antibodies overnight at 4℃, 
and then appropriate secondary and DAPI at 37 °C for 2 h.  Following washing, the stained coverslips 
were mounted using the ProLong Diamond Antifade mounting medium for image collections. 
 
Neuronal culture, treatment and immunostaining 
Hippocampal neuronal cultures were prepared from postnatal day 1 (P1) pups as previously 
described49,50 with minor modifications.  Briefly, hippocampal CA1 regions were dissected in ice-cold 
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0.1 M PBS, tissues were trypsinized (0.25%) at 37 oC for 15 min, dissociated by trituration, and plated 
onto poly-D-lysine (50 µg/ml) coated glass coverslips (60,000 cells/ml).  The cultures were maintained 
by replacing half of the medium with fresh medium every 3-4 days.  The maintenance medium 
contained Neurobasal A, 0.5 mM GlutaMax and B27.  At 17-18 DIV, neurons were either treated with 
D-AP5 (50 μM) or fresh neurobasal medium for 10 min, then with NMDA (25 μM) or glycine (200 M) 
for 3 min, to trigger AMPAR endocytosis or surface delivery.  Following the treatment, neurons were 
washed with PBS and incubated at 37 oC in fresh conditional medium for additional 10 min.  The cells 
were then fixed with ice-cold 4% paraformaldehyde and 4% sucrose for 30 min.  For surface GluA2 
staining, the fixed cells were blocked with 5% FBS in 0.1M PBS for 1 h and incubated with GluA2-
NTD antibody overnight at 4oC.  The cells were then permeabilized with 0.25% TritonX-100 for 30 min, 
blocked again with 5% FBS in 0.1M PBS again for 1 h, and incubated with either GluA2 or 
synaptophysin antibody for at least 8 h at 4 oC.  For permeabilized (total protein) staining, the fixed cells 
were immediately treated with 0.25% TritonX-100 for 30 min before being blocked with 5% FBS in 
0.1M PBS for 1 h and incubation with primary antibodies overnight at 4 oC.  After the primary antibody 
incubation, cells were incubated with rhodamine-conjugated phalloidin or appropriate secondary 
antibodies for 1 h at room temperature. After washing with 0.1M PBS, coverslips were mounted using 
the ProLong Diamond Antifade mounting medium for image collection. 
 
Microscope setups, image collection and analysis  
For spine analyses, confocal images were obtained at room temperature using a Zeiss LSM 700 at 2048 
×2048 pixels using Zeiss 63× (NA 1.4, oil immersion) objective with the same settings and 
configurations for all samples within each experiment.  Spines were defined as any dendritic protrusions 
of 0.3-4 µm in length.   For analyses of synaptic proteins, the fluorescence puncta (with an area of 
greater than 0.1 µm2) were automatically selected and counted and manually verified.  For each 
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treatment, approximately 10-25 neurons from at least 3 independent cultures and a total of 100-150 μm 
linear dendrites per neuron were randomly selected, measured and averaged.  For immunohistochemistry 
staining, confocal images were obtained at room temperature on Zeiss LSM 700 at 2048 ×2048 pixels 
using Zeiss 5× (NA 0.15, dry) objective with the same settings and configurations for all samples within 
each experiment.  The fluorescence puncta from CA1 apical dendritic areas were selected and counted 
and manually verified.  All images were initially acquired through the Zen 2010 software (Zeiss).  
AimImageBrowser (Zeiss) software was used to adjust the image brightness/contrast and to extract a 
sub-region.  All measurements were performed using the ImageJ (NIH) software. 
 
Western blot analysis and immunoprecipitation 
Whole brain protein lysates were prepared from 3 to 5 week-old mutant and their WT control littermates 
as previously described50.  One mouse brain was homogenized in a Dounce homogenizer with 1.5 ml 
ice-cold lysis buffer containing (in mM): 20 Tris-HCl (pH 7.5), 150 NaCl, 1 EDTA, 1 EGTA, 1% Triton 
X-100, 2.5 sodium pyrophosphate, 1 β-glycerophosphate, 1 Na3VO4, 20 NaF, and 1% protease inhibitor 
cocktail and phosphatase inhibitor (Roach) and kept at 4 ℃ for 40 min before debris was removed by 
centrifugation at 14,000g for 10 min.  The protein samples were either stored or mixed with 25% 
volume of 5×SDS loading buffer (250 mM Tris-HCl, 10% SDS, 0.5% bromophenol blue, 50% glycerol, 
5% beta-mercaptoethanol, pH 7.4) for electrophoresis on a SDS-PAGE ployacrylamide gel and 
electrotransfered to a PVDF filter.  The filter was then blocked with 5% dry milk in TBST (20 mM Tris-
HCl, 9% NaCl, 1% Tween-20, pH 7.6) and incubated overnight at 4 ℃ with suitable primary antibodies 
in TBST.  Following washing and incubation with appropriate secondary antibodies, the filter was 
washed extensively and developed using an enhanced chemiluminescence (Thermo) method of detection 
and analyzed using the AlphaEaseFC software as per manufacturer’s instruction.  The amount of total 
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protein loaded was controlled by normalizing each tested protein with anti-tubulin immunoreactivity on 
the same blot.  For the biotinylation experiments of acute slices, protein loading and surface biotin 
labeling efficiency were further controlled by normalizing the protein of interest (i.e. surface GluA2) 
with the anti-Pan-Cadherin immunoreactivity on the same blot.  For immunoprecipitation experiments, 
300 µl of the protein lysate (200–300 µg, normally pooled from 1/5 to 1/4 whole brain lysate) was 
incubated with GluA1-NTD or GluA2-NTD antibodies at 4°C with constant gentle rocking over night, 
followed by addition of 30 µl of Protein A/G agarose beads slurry (Santa Cruz Biotechnology, Inc.) and 
further incubation for 4 h at 4°C.  The beads were carefully harvested and washed thoroughly with the 
lysis buffer five times and resuspended in loading buffer for Western blot analysis. 
 
Biotinylation and immunofluorescence assays of surface AMPARs in hippocampal slices  
Brain slices were prepared according to the same procedure as for electrophysiological recordings.  
Slices were recovered at room temperature in ACSF saturated with 95% O2 /5% CO2 for 3-4 hours.  
Then slices were then transferred to a treatment chamber containing the same 95% O2 /5% CO2 
saturated ACSF and treated with NMDA (25 μM), glycine (200 M) or ACSF alone for 3 min at room 
temperature.  For biotinylation assay, after 10 min recovery in the saturated ACSF, slices were 
transferred to a labeling chamber and incubated with 1 mM Biotin-XX, SSE (B6352, Thermo) in ACSF 
at 4 ℃.  30 min later, the slices were quenched three times with 20 mM Tris-HCl (pH 7.35) at 4 ℃ for 
10 min.  After the labeling, slices were rapidly placed into ice-cold lysis buffer, and lysed for 45 
minutes.  Debris were removed by centrifugation at 14,000 g in 4 ℃ for 10 min.  Each (400 μl) of the 
biotin-labeled supernatant samples was incubated with 50 μl of lysis buffer prewashed streptavidin-
coated magnetic bead slurry (65801D, Thermo) overnight at 4℃ with gentle rotation.  The beads were 
washed with ice-cold lysis buffer for 5 times before being resuspended in 40 μl 2×SDS buffer (100 mM 
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Tris-HCl, 4% SDS, 0.2% bromophenol blue, 20% glycerol, 2% beta-mercaptoethanol, pH 7.4).  Samples 
were separated on SDS-PAGE polyacrylamide gel for western blot analysis.  For immunofluorescence 
staining, after 20 min recovery in the saturated ACSF, slices were fixed in 4% PFA for 4 h, and then 
transferred to 30% sucrose in PBS solution till it was saturated. Then the slices was embedded in Tissue-
Tek® O.C.T. compound, frozen in liquid nitrogen and stored at - 80 °C, before being sliced to 25 μm 
coronal crystat sections at -20 °C (Leica CM1950). 
 
Behavioral tests 
Previously described procedures for animal handling and testing29,49 were followed with some 
modifications as detailed below.  
Subjects.  Animals were tested at the age of 3 ± 0.5 months.  The CTD replacement mutant and their WT 
littermate control groups were sex-balanced and handled daily for three days before the following 
experiments. All the behavioral tests were performed during the light cycle. The mice were tested in 
open field, then elevated plus maze and finally water maze, with one week interval between these tests. 
Separate groups of mice were used for the fear memory test.  
Open field test.  The open field apparatus is a rectangular plexiglass box (35×35×35 cm) comprising of 
four walls and an open roof.  The illumination in the room was provided by centrally placed in-ceiling 
dim lights.  All mice were individually tested in one 5 min session.  Each subject was introduced to the 
apparatus in the same place of the arena near the center and allowed to explore the maze for 5 min.  The 
apparatus was cleaned thoroughly with 75 % ethanol before each subject was tested.  The movement of 
the mouse was video tracked and analyzed off-line using ANY-maze software (USA).  The box was 
divided into central (center 15 cm diameter) and peripheral fields for analysis.  
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Elevated plus maze test.  The elevated plus maze was made of two open arms (30×5 cm) without any 
walls and two enclosed arms (30x5 cm) with 15 cm high walls on each side.  These arms were elevated 
60 cm above the ground.  Again all mice were individually tested in one 5 min session.  The mouse was 
placed in the center of the maze and allowed to explore for 5 min.  The maze was cleaned thoroughly 
with 75 % ethanol before each mouse was tested.  Traces of movement were tracked and analyzed off-
line using ANY-maze software (USA). 
Water maze test.  The water maze consisted of a circular pool (120 cm diameter) filled with water (22 ± 
2°C).  The water was made opaque with non-toxic white chalk.  The platform (10 cm wide) was located 
approximately 1 cm below the water level.  On the first 3 days, the mice were trained to locate a visible 
platform (indicated with a visible red flag).  Each subject was given four trials (with 1.5 h inter-train 
interval) per day.  Each trial began by placing the mouse in the water, near and facing the wall of the 
pool.  The starting points for each subject were chosen randomly from any of the three quadrants other 
than the one with the platform.  Each subject was allowed 60 s to find the platform and if it failed to 
reach the platform within 60 s, it was guided by the experimenter to the platform and allowed to stay on 
the platform for 10 s.  The mice that did not reach the platform during a trial were assigned a latency of 
60 s.  Upon removal from the maze, the mice were dried with absorbent papers, placed on a warm 
platform and returned to their home cages.  After the visible platform test was completed, the mice were 
then trained for the next eight or nine days to locate a hidden platform with three or four training trials 
per day (with 3-4 h inter train interval).  Short-term or long-term memory tests were conducted by probe 
trials (platform removed) 2 h or 24 h after the last trial on the last day of the hidden platform training.  
The entire travel of the mouse was tracked and analyzed off-line with ANY-maze software.  The time 
that the mouse spent in the target quadrant or target zone (30 cm diameter around the platform) during 
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the probe trial was used as a measure of spatial memory retention. Mice with more than 20 s of floating 
during learning acquisition were excluded from analysis.  
Contextual and cued conditioned fear.  The conditioning chamber contained one foot-shock box (30 × 
26 × 30 cm) with a speaker and a light (Freeze Frame, USA).  The floor of the box consisted of stainless 
steel bars that were connected to a computer, which controlled the duration of a test session, timing, and 
intensity and duration of the shock or sound.  Background noise was 55 dB.  The subject mouse was 
allowed to explore the chamber for 300 s before the onset of a discrete conditioned stimulus (CS), which 
consisted of continuous sound (2000 Hz, 80 dB) lasting 40 s.  During the last 2 s of this CS period a 
subject was exposed to an unconditioned stimulus (US), a continuous foot shock (0.7 mA).  This CS-US 
training paradigm was repeated two or three times with an inter-train interval of 40 s.  10 s later, mice 
were removed from the chamber and returned to their home cages.  Approximately 2 h or 24 h later, 
subjects were given a 3 min contextual conditioning test in the same chamber where they were trained.  
The cued test (7 min) was performed 2 h after the contextual test.  For the cued test the chamber was 
completely altered by covering the floor and walls with gray paperboard.  During the first 5 min of the 
test the CS was not presented (pre-CS stage), after which subjects were exposed to the same tone given 
during the training but without any foot shocks.  In the context pre-exposure version of the fear 
conditioning paradigm, each mouse was allowed to explore the conditioning chamber for 4 min without 
any foot shocks or tone.  On the following day, the mouse was placed back to the chamber and 
immediately given two foot shocks (0.7 mA, each lasting 2 s with a 1 s interval).  The mouse was 
removed from the chamber right after the shocks.  24 h later the mouse was tested for 3 min for a 
freezing response in the conditioning chamber.  The chamber was cleaned with 10% alcohol after each 
subject was trained or tested.  Behavior of the mice was recorded and analyzed off-line using automated 
motion detection software Freeze Frame (USA). 
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Statistical Methods 
All the averaged data in the graphs were stated as mean ± SEM and statistically evaluated by Student’s 
t-test for comparisons of two groups, or ANOVA (one-way, two-way or repeated measures wherever 
appropriate) for comparisons of more than two groups followed by post-hoc Fisher’s LSD multiple 
comparison test using the SPSS program.  p < 0.05 was considered as significant (*p < 0.05, **p < 0.01, 
***p < 0.001).  The variances within groups were estimated before comparison between 
groups/treatments was carried out and in cases where the assumptions were not met, Greenhouse-
Geisser corrections were used.  Mean ± SEM values, samples sizes, p values and statistical methods are 
defined in respective figure legends.  No statistical methods were used to pre-determine sample sizes but 
our sample sizes are similar to those reported in previous publications (e.g., ref 10,19-21).  Complete 
statistics data are reported in “Statistics data reporting by Figure”. 
 
References for Methods: 
49. Meng, Y. et al. Abnormal spine morphology and enhanced LTP in LIMK-1 knockout mice. 
Neuron 35, 121-133 (2002). 
50.  Zhou, Z. et al. GluA2 (GluR2) regulates metabotropic glutamate receptor-dependent long-term 
depression through N-cadherin-dependent and cofilin-mediated actin reorganization. J. Neurosci. 
31, 819-833 (2011). 
 
Data Availability: 
All supplementary information is available in the online version of the paper. All other source data are 
available from the corresponding author (Zhengping Jia) upon reasonable request. 
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Fig. 6 
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Fig. 8 
 
